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Abstract 
In addition to the smal and large ribosomal subunits, aminoacyl-tRNAs, and 
mRNA, celular protein synthesis is dependent on translation factors. Since its discovery 
nearly  40  years ago, eIF5A is  one such factor that has remained a  mystery. eIF5A  was 
initialy characterized based on its ability to stimulate methionyl-puromycin synthesis, a 
model assay for protein synthesis; however, the function of this factor in celular protein 
synthesis has been dificult to resolve. Interestingly, eIF5A is the sole celular protein to 
contain the  post-translational hypusine modification.  Hypusine formation requires the 
conserved enzymes deoxyhypusine synthase and deoxyhypusine  hydroxylase for its 
biosynthesis. This  dissertation focuses  on the novel role of the translation factor eIF5A 
and its  hypusine  modification in the elongation  phase  of  protein synthesis. Combining 
yeast  genetic and  biochemical techniques, we  uncover new functional and  mechanistic 
insights for the role of eIF5A and its hypusine modification in translation. Similar to its 
bacterial homolog EF-P, eIF5A stimulates the production of proteins containing runs of 
consecutive proline residues. In addition, genome-wide ribosome profiling studies reveal 
ribosomal pausing and  drop-of on mRNA sequences encoding polyproline.  Moreover, 
molecular analyses  of eIF5A  mutants  dependent  on the conserved  hydroxyl  group  on 
hypusine demonstrate that the second step  of  hypusine synthesis contributes to the 
translation function of the factor.  Taken together, these  discoveries  delineate the 
extraordinary role of eIF5A and its hypusine modification in the synthesis of polyproline 
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1.1 Protein synthesis requires dedicated translation machinery 
The translation of mRNAs to generate proteins is a fundamental atribute of the central 
dogma  of  molecular  biology and requires  dedicated translation machinery to facilitate 
celular  protein synthesis.  Composed  of  distinct initiation, elongation, termination, and 
recycling stages, protein synthesis is the  process in which the ribosome, the  protein-
synthesizing engine of the cel, uses a template mRNA to guide the step-wise addition of 
amino acids to form  polypeptides. In addition to  mRNA, aminoacyl-tRNAs, and the 
smal and large ribosomal subunits, translation factors are also required to  promote the 
production of proteins. As translation factors are among the most abundant proteins in the 
cel, they are also  prolific energy consumers as some factors  bind guanosine-5’-
triphosphate (GTP) to drive the diferent stages of protein synthesis.  
Translation initiation is the first and typicaly rate-limiting stage of translation. In 
this  phase  of eukaryotic translation, initiation factors assist in:  1) the  delivery  of the 
initiator  methionyl-tRNA (Met-tRNAi
Met) to the  40S subunit,  2) the  binding  of the 
resulting 43S complex to an mRNA, and 3) the assembly of an 80S ribosome on a start 
codon (reviewed in Hinnebusch and  Lorsch,  2012).  Whereas translation initiation 
requires at least eleven factors in eukaryotes (eIFs),  bacteria  need  only three initiation 
factors (IFs) (reviewed in Simoneti et al.,  2009).  The  diference in factor requirements 
between eukaryotes and  bacteria can  be atributed to the  direct targeting  of the smal 
ribosomal subunit to the translation start site in bacteria by the Shine-Dalgarno sequence 
versus the 5’-cap-dependent scanning mechanism in eukaryotes.  
Once the eukaryotic  80S ribosome is  positioned  on an mRNA  with a  Met-
tRNAi
Met anticodon  base-paired  with the start codon, the ribosome is ready for the 
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elongation  phase  of  protein synthesis.  At this stage, the  80S ribosome consists  of three 
distinct sites for translation of the mRNA sequence: an A site, a P site, and an E site. The 
ribosomal A site is the destination for aminoacyl-tRNAs except for the first aminoacyl-
tRNA  which is  bound to the  P site.  The aminoacyl-tRNA that enters the  A site is the 
acceptor for the growing polypeptide chain during peptide bond formation. The P site is 
the location of the peptidyl-tRNA atached to the growing polypeptide chain. The E site 
contains a deacylated tRNA that is ready for exiting the ribosome.  
While  bacteria and eukaryotes  have largely  distinct  mechanisms for translation 
initiation, the elongation  phase is  very similar in  mechanism and  highly conserved in 
factor requirements (reviewed in Dever and Green, 2012). In the elongation stage (Fig. 1), 
the eukaryotic elongation factors (eEFs) eEF1A (EF-Tu in bacteria) and eEF2 (EF-G in 
bacteria)  have largely  defined functions.  With  peptidyl-tRNA in the  P site, the eEF1A 
ternary complex (eEF1A–GTP–aminoacyl-tRNA) binds the vacant ribosomal A site in a 
codon-dependent  manner.  Upon codon recognition  by the tRNA,  GTP is  hydrolyzed 
resulting in release of eEF1A and accommodation of the aminoacyl-tRNA in the A site. 
As seen in bacterial ribosomes, it is thought that high fidelity decoding of the mRNA is 
dependent  on the ability  of the  EF-Tu–GTP–aminoacyl-tRNA to  bind the  A site and to 
facilitate interactions with the 16S rRNA (reviewed in Schmeing et al., 2009; Schmeing 
et al., 2011). 
After accommodation of the cognate aminoacyl-tRNA to the A site, the ribosome 
then catalyzes  peptide  bond formation  between the  peptidyl-tRNA in the  P site and the 
aminoacyl-tRNA in the A site. This peptidyl transferase reaction is facilitated by rRNA 
through a  nucleophilic atack  of the α-amino  group  of the aminoacyl-tRNA  on the 
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(Top)  An  EF-Tu(eEF1A)–GTP–aminoacyl(aa)-tRNA ternary complex (TC)  binds aa-
tRNA to the A site of the 70S (eukaryotic 80S) ribosome in a codon-dependent manner. 
(Middle right) Folowing release of EF-Tu–GDP, the aa-tRNA is accommodated into the 
A site. Peptide bond formation (lower right) is folowed by binding of EF-G (eEF2)–GTP 
(lower left),  which  promotes translocation  of the  deacylated tRNA and  peptidyl-tRNA 
into the canonical E and P sites, respectively. (Middle left) Folowing release of EF-G–
GDP, the ribosome is ready for the next cycle of elongation.  
 
Next, the large and smal subunits assume a ratcheted state alowing for 
movement  of the tRNAs into  hybrid  P/E and  A/P states  with the acceptor ends  of the 
tRNAs in E and P sites and the anticodon loops at the P and A sites. The factor eEF2/EF-
G  promotes the translocation  of the tRNAs and  mRNA  on the ribosome leaving the 
deacylated tRNA and the peptidyl-tRNA in the canonical E and P sites, respectively. It is 
thought that the GTPase eEF2/EF-G bound to GTP stabilizes the hybrid state and, upon 
binding the ribosome, results in GTP hydrolysis and inorganic phosphate (Pi) release. It is 
also  presupposed that  Pi release can  de-ratchet the ribosome relieving the  hybrid state 
conformation and alowing movement of the tRNAs and mRNA (Dever and Green, 2012). 
In the post-translocation state, eEF2/EF-G is released and the A site is open for delivery 
of the  next eEF1A–GTP–aminoacyl-tRNA ternary complex for an additional round  of 
elongation. When the ribosome encounters a stop codon (UAA, UGA, or UAG) in the A 
site, release factors bind the A site and promote hydrolysis of the peptidyl-tRNA linkage, 
releasing the completed polypeptide chain from the ribosome. Then, ribosome recycling 
factors  promote the  dissociation  of the ribosome, tRNA and  mRNA.  Thus,  by their 
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interactions  with  various components  of the translation machinery, translation factors 
play essential roles in facilitating protein synthesis. 
My thesis  project focuses  on the role  of the translation factor eIF5A and its 
enigmatic  hypusine  modification in  protein synthesis. eIF5A  was first identified in the 
early  1970s  when  purified from rabbit reticulocyte lysates and found to stimulate 
methionyl-puromycin (Met-Pmn) peptide synthesis, a  model assay for translation that 
monitors the transfer  of a  methionine from  Met-tRNA in the ribosomal  P site to 
puromycin, an aminoacyl-tRNA analog that  binds in the  A site. Based  on this activity, 
this assay was interpreted as an indicator of first peptide bond formation and thus, eIF5A 
was linked to a role in translation initiation (Benne and Hershey, 1978). However, more 
recent  genetic and  biochemical studies  on eIF5A demonstrate a  prevalent role for the 
factor in the elongation phase of protein synthesis (Saini et al., 2009; Zaneli et al., 2006). 
In a celular context, eIF5A  has also  been implicated in  nucleocytoplasmic transport 
(Bevec et al.,  1996; Hofmann et al.,  2001; Ruhl et al.,  1993) and  mRNA stability 
(Schrader et al., 2006; Zuk and Jacobson, 1998). Furthermore, eIF5A has been linked to 
oncogenesis,  diabetes, and  HIV-1 infections (reviewed in Kaiser,  2012). Presumably, 
these celular  processes are regulated at the level  of translation  by eIF5A and,  when 
dysfunctional, can result in disease.  
In this thesis, I discuss the role of eIF5A and its hypusine modification in protein 
synthesis. First, I give a comprehensive overview of the field prior to the time I joined the 
Dever lab in early  2011.  Next, I relate eIF5A to the translation field and  present the 
outstanding questions circa 2011 and the objectives of my research. Then, I present my 
key findings and results. Finaly, I end with a discussion on the major developments in 
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the field during my time in the Dever lab, the impact and implications of our work in the 
field, and propose future areas of research. 
 
1.2 The discovery of eIF5A and its bacterial homolog EF-P 
eIF5A and its  bacterial  ortholog  EF-P  were identified  by their isolation from celular 
extracts. Initialy, in vitro reconstituted  model assays  were  used to characterize the 
functions of these factors and to define their actions during discrete phases of translation. 
Purified from rabbit reticulocytes, eIF5A (originaly  named IF-M2Bα  or eIF-4D)  was 
identified as an abundant 17 kDa protein and shown to stimulate the overal yield of Met-
Pmn synthesis in assays containing 80S ribosomes, the known complement of initiation 
factors (eIF2, eIF1A, eIF3, and eIF5) and the trinucleotide 5’-AUG-3’ mRNA (Benne et 
al., 1978; Benne and Hershey, 1978; Kemper et al., 1976; Schreier et al., 1977). In this 
assay,  80S initiation complexes  were first assembled  with Met-tRNAi
Met in the P site. 
Then, the assay  monitored the transfer  of  methionine to  puromycin, a  partial  mimic  of 
aminoacyl-tRNA that  binds to the ribosomal  A site. Interestingly, eIF5A  did  not afect 
other  model assays for translation initiation such as  43S  pre-initiation  or 80S initiation 
complex formation (Benne and  Hershey,  1978; Schreier et al.,  1977).  However,  based 
upon the ability to stimulate  Met-Pmn synthesis,  but  not  other assays  monitoring early 
steps  of translation initiation, it  was  proposed that eIF5A functioned to  promote 
formation of the first peptide bond or to facilitate the transition from the initiation to the 
elongation phase of protein synthesis (Benne and Hershey, 1978). It is also notable that 
puromycin is an aminonucleoside antibiotic and  has  been shown to  be an imperfect 
substrate due to its poor positioning in the ribosome active site (Wohlgemuth et al., 2008; 
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Youngman et al.,  2004).  Nevertheless, the stimulation  of Met-Pmn synthesis could 
indicate roles for eIF5A in first  peptide  bond synthesis,  general translation elongation, 
and/or the reactivity of poor substrates, like puromycin, in the ribosome active site. 
Along  with its ability to stimulate  Met-Pmn synthesis, eIF5A  was found to 
stimulate the  overal  yield  of  polyphenylalanine (encoded  by a  polyU  mRNA) 
synthesized by 80S ribosomes at low Mg2+ concentrations (Kemper et al., 1976). When 
assayed at  10  mM  Mg2+, synthesis  of  polyphenylalanine required  only translation 
elongation factors;  however, at low  Mg2+ concentrations this assay also required the 
initiation factors eIF1A, eIF2A (now caled eIF2D), eIF5B, and eIF5A (Merick, 1979a), 
though the role of initiation factors in this assay was not clear. The 2-4–fold stimulatory 
activity  of eIF5A in the  polyphenylalanine and  Met-Pmn synthesis assays,  which  both 
monitored the formation  of a  peptide  bond,  was consistent  with the  notion that eIF5A 
functions in translation elongation.  However,  when eIF5A  was added to assays 
monitoring the synthesis of globin protein chains, it failed to stimulate globin synthesis. 
Arguably, this result  was inconsistent  with a role for eIF5A throughout translation 
elongation.  While this apparent lack  of activity  might  be atributed to the  presence  of 
eIF5A in the  post-ribosomal supernatant and crude aminoacyl-tRNA synthetase  preps 
used for the globin synthesis assays (Merick, 1979b; Thomas et al., 1979), the addition 
of eIF5A  did  not stimulate the  yield  of  globin synthesis in reconstituted assays  using 
purified aminoacyl-tRNAs and thus lacking this proposed eIF5A contamination (Schreier 
et al., 1977). In additional in vitro experiments, eIF5A lowered the Mg2+ requirement for 
globin synthesis in assays lacking spermidine (Schreier et al.,  1977).  However,  when 
similar assays  were conducted in the  presence  of spermidine at the low  Mg2+ 
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concentration, eIF5A  did  not exhibit a stimulatory efect.  The authors  proposed that 
eIF5A could  have a role in  protein synthesis aside from translation initiation,  perhaps 
mimicking the role  of  polyamines  during  protein synthesis though the function  of 
polyamines is unclear. 
Concurent  with the  discovery  of eIF5A in rabbit reticulocytes and its 
characterization in  model assays  of  protein synthesis, the bacterial  ortholog of eIF5A 
caled EF-P  was  purified from E. coli extracts  with  >90% in the  post-ribosomal 
supernatant. EF-P  was shown to stimulate formylmethionyl (fMet)-Pmn synthesis in an 
assay consisting  of  70S ribosomes, [35S]fMet-tRNAMet,  mRNA, and  puromycin.  Based 
upon this initial  observation,  EF-P  was  proposed to  be an elongation factor that 
functioned to promote peptide bond synthesis on the ribosome (Glick and Ganoza, 1975). 
In a subsequent study,  EF-P  was found to  diferentialy stimulate  dipeptide synthesis 
between fMet-tRNA and the cytidyl-aminoacyladenosine (C-A) analogs  of the acceptor 
ends of various aminoacyl-tRNAs. Interestingly, the EF-P stimulatory activity was most 
pronounced for the  A-site substrates  C-A-Gly,  puromycin, and  C-A-Ala, leading to the 
hypothesis that  EF-P  promoted the activity  of  poor substrates (smaler and/or less 
hydrophobic side chains) for  peptidyl transfer (Ganoza and  Aoki,  2000; Glick et al., 
1979). 
Intriguingly, eIF5A is the only known celular protein to contain the amino acid 
hypusine (N
ε
-(4-amino-2-hydroxybutyl)lysine) (Park et al., 1981). Hypusine was initialy 
identified as a free and unatached amino acid isolated from bovine brain, and was later 
reported to  be  widely  distributed in  other tissues. Hypusine is  highly  basic and  was 
named for its component parts: hydroxyputrescine and lysine (Shiba et al., 1971). When 
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cultured mammalian cels were grown in the presence of [3H]spermidine, eIF5A was the 
single labeled  protein resolved  by two-dimensional  gel electrophoresis (Cooper et al., 
1982; Cooper et al., 1983; Park et al.,  1981).  The size (~17  kDa) and  pI (~5.1)  of the 
hypusine-containing  protein, as  wel as the  direct corelation  of increased  hypusine 
labeling  with increased rates  of  protein synthesis in  mammalian cels, led to the 
hypothesis that  hypusine  plays a critical role in celular  protein synthesis.  Furthermore, 
the  detection  of  hypusine in acid  hydrolysates  of  highly  purified eIF5A confirmed its 
identity as the sole hypusine-containing protein (Cooper et al., 1983). Finaly, cloning of 
eIF5A and comparison  of the  predicted amino acid sequence from the cDNA  with the 
observed sequence based on Edman degradation revealed that Lys50 was the site of the 
hypusine  modification in  mammalian eIF5A (Park et al.,  1986; Smit-McBride et al., 
1989a). Further genome sequencing eforts and spermidine labeling studies revealed that 
the  hypusine (or at least deoxyhypusine) modification is conserved in al eukaryotic 
eIF5A and archaeal aIF5A proteins (Bartig et al., 1992; Bartig et al., 1990; Gordon et al., 
1987a; Park et al., 1997). Moreover, despite the absence of hypusine in bacteria, amino 
acid sequence comparisons revealed that bacterial EF-P, eukaryotic eIF5A and archaeal 
aIF5A are  homologs (Kyrpides and  Woese,  1998). Given their common ability to 
stimulate  Met-Pmn synthesis assays, it  was reasonably  proposed that eIF5A and  EF-P 
perform similar functions in celular protein synthesis (Saini et al., 2009). 
 
1.3 Structural analysis of eIF5A/EF-P and EF-P bound to 70S ribosomes 
Both yeast and humans express two eIF5A proteins, and the two forms of eIF5A within 
each organism share strong (80-90%) amino acid sequence identity. Moreover, the eIF5A 
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proteins in  yeast,  humans, and fruit fly consist  of  153-159 residues and share  >50% 
amino acid sequence identity  with the  highest  degree  of amino acid similarity existing 
near the site  of the  hypusine  modification (Fig.  2).  The archaeal aIF5A shows strong 
similarity to the eukaryotic factor, though archaeal aIF5A is truncated  by around  10 
residues at the N-terminus compared to the eukaryotic factor. Bacterial EF-P is around 30 
residues longer than eIF5A (Fig.  2), and  based  on  multiple sequence alignments these 
extra residues are inserted in the C-terminal half of the protein. It is noteworthy that the 
sequence flanking the site of hypusine modification K-x-G-Hyp-H-G-x-A-K is conserved 
among eukaryotes and archaea. Four of the residues in this motif (Lys, both Gly, and Ala) 
are also conserved in  EF-P,  while the  His residue is  not  present in  EF-P and the  Lys 
residue that is  modified to  hypusine is conserved in  EF-P from E. coli but substituted 
with Arg in T. thermophilus EF-P (Fig. 2). 
The crystal structures  of eIF5A and  EF-P from several eukaryotes, archaea and 
bacteria have been solved and the proteins show significant structural similarity. aIF5A 
from M. jannaschi (Kim et al., 1998), P. aerophilum (Peat et al., 1998), and P. horikoshi 
(Yao et al., 2003), and eIF5A from human (Tong et al., 2009) and yeast (pdb code 3ER0) 
fold into a two  domain structure  with residues  ~1-83 forming the  N-terminal  domain. 
This N-terminal domain consists of six β-strands that fold into a partialy open β-barel 
(Kim et al., 1998), while the C-terminal domain, consisting of 3-5 β-strands and 0-2 α-
helices, resembles an  OB-fold type  of β-barel  domain (Kim et al.,  1998; Peat et al., 
1998; Yao et al., 2003) (Fig. 3). In al structures, the highly conserved residues flanking 
the site  of  hypusine  modification are in a long  unstructured loop (the  hypusine loop) 
between strands β3 and β4 that protrudes from the N-terminal domain (Fig. 3). 
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Figure 2. Sequence alignment of eIF5A and EF-P.  
Multiple sequence alignment  of  yeast (Saccharomyces cerevisiae, Sc)  Hyp2 (Tif51A; 
eIF5A1) and Anb1 (Tif51B, eIF5A2), human (Hs) eIF5A1 and eIF5A2, fly (Drosophila 
melanogaster,  Dm) eIF5A, archaeal (Methanococcus jannaschi,  Mj, and Haloarcula 
marismortui, Hm) aIF5A, and bacterial (Escherichia coli, Ec, and Thermus thermophilus, 
Tt) EF-P was performed using Clustal X (v2.0). Residues in red are identical in al eIF5A 
and EF-P proteins; residues in blue are identical only in eIF5A and aIF5A; and residues 
in yelow are conserved in eIF5A and EF-P. Secondary structure elements are shown at 
the top (eIF5A) and botom (EF-P) of the sequences (arow = β-strand, loops = α-helix). 
The lysine residue that is modified to hypusine in eIF5A and aIF5A and β-lysinylated in 





β1 β2 β3 β4 β5
β6 β7 β8 β9 β10 β11 β12
β13 β14 β15 β16
  
Sc-Hyp2      MSDEEHTFETADAGSSATYPMQCSALRKNGFVVIKSRPCKIVDMSTSKTGKHGHAKVHLVAIDIFTGKKLEDLSPSTHNM  80 
Sc-Anb1      MSDEEHTFENADAGASATYPMQCSALRKNGFVVIKGRPCKIVDMSTSKTGKHGHAKVHLVTLDIFTGKKLEDLSPSTHNL  80 
Hs-5A1       MAD-DLDFETGDAGASATFPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHNM  79 
Hs-5A2       MAD-EIDFTTGDAGASSTYPMQCSALRKNGFVVLKGRPCKIVEMSTSKTGKHGHAKVHLVGIDIFTGKKYEDICPSTHNM  79 
Dm           MAELDDQFETTDSGASTTYPMQCSALRKNGFVMLKSRPCKIVEMSTSKTGKHGHAKVHMVGIDIFSNKKYEDICPSTHNM  80 
Mj           -----------MIIMPGTKQVNVGSLKVGQYVMIDGVPCEIVDISVSKPGKHGGAKARVVGIGIFEKVKKEFVAPTSSKV  69 
Hm           --------------MAR-EQTEVRELDEGSYVMIEDTPCKINSYSTAKPGKHGSAKARIDAKGVFDGKKRSLSQPVDAKV  65 
 
Ec           --------------MATYY---SNDFRAGLKIMLDGEPYAVEASEFVKPGK-GQAFARVKLRRLLTGTRVEKTFKSTDSA  62 
Tt           --------------MIS-----VTDLRPGTKVKMDGGLWECVEYQHQKLGR-GGAKVVAKFKNLETGATVERTFNSGEKL  60 
 
  
Sc-Hyp2      EVPVVKRNEYQLLDIDDG-FLSLMNMDGDTKDDVK-----------------------------------------APEG  118 
Sc-Anb1      EVPFVKRSEYQLLDIDDG-YLSLMTMDGETKDDVK-----------------------------------------APEG  118 
Hs-5A1       DVPNIKRNDFQLIGIQDG-YLSLLQDSGEVREDLR-----------------------------------------LPEG  117 
Hs-5A2       DVPNIKRNDYQLICIQDG-YLSLLTETGEVREDLK-----------------------------------------LPEG  117 
Dm           DVPNVKREDLQLIAISDDSFLTLMTESGDLREDLK-----------------------------------------VPEG  119 
Mj           EVPIIDRRKGQVLAIMGD-MVQIMDLQTYETLELP-----------------------------------------IPEG  107 
Hm           WVPIVNRKQGQVVSTDGN-DAQVMDLDTYDTFTMR-----------------------------------------VPED  103 
 
Ec           EGADVVDMNLTYLYNDGE-FWHFMNNETFEQLSADAKAIGDNAKWLLDQAECIVTLWNGQPISVTPPNFVELEIVDTDPG  141 
Tt           EDIYVETRELQYLYPEGE-EMVFMDLETYEQFAVPRSRVVG-AEFFKEGMTALGDMYEGQPIKVTPPTVVELKVVDTPPG  138 
 
  
Sc-Hyp2      ELGDSLQ-----TAFDEGKDLMVTIISAMGEEAAISFKEAARTD  157 
Sc-Anb1      ELGDSMQ-----AAFDEGKDLMVTIISAMGEEAAISFKEAPRSD  157 
Hs-5A1       DLGKEIE-----QKYDCGEEILITVLSAMTEEAAVAIKAMAK    154 
Hs-5A2       ELGKEIE-----GKYNAGEDVQVSVMCAMSEEYAVAIKPCK    153 
Dm           ELGEQLR-----LDFDSGKDLLCTVLKACGEECVIAIKTNTALDK  159 
Mj           IEGLEPG-----GEVEYIEAVGQYKITRVIGGK             135 
Hm           ID-LQPD-----DEIEYLQYEEQRKITRS                 126
 
Ec           LKGDTAGTGGKPATLSTGAVVKVPLFVQIGEVIKVDTRSGEYVSRVK  188 
Tt           VRGDTVSGGSKPATLETGAVVQVPLFVEPGEVIKVDTRTGEYVGRA  184 
β9
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E. coli EF-P is denoted by the red dot above the alignment. Figure is from Dever et al. 
(Dever et al., 2014). 
 
In contrast to the two-lobed structure  of eIF5A,  EF-P is composed  of three 
domains (Hanawa-Suetsugu et al., 2004) (Fig. 3). The N-terminal domain I of EF-P can 
be superimposed on the N-terminal domain of eIF5A, while domains I and II of EF-P 
share structural similarity  with  one another and  with the  C-terminal  domain  of eIF5A 
(Fig. 3). The three domains of free EF-P are aranged in an L-shaped configuration that 
resembles the structure  of tRNA (Hanawa-Suetsugu et al.,  2004). In support  of this 
structural resemblance, the co-crystal structure of EF-P bound to the T. thermophilus 70S 
ribosome revealed that EF-P binds adjacent to the P-site tRNA in a location that partialy 
overlaps the E site of the ribosome (Blaha et al., 2009) (Fig. 4). Domain I of EF-P binds 
near the acceptor stem of the P-site tRNA and contacts the large ribosomal subunit, while 
domain II of EF-P is located adjacent to the anticodon of the P-site tRNA and partialy 
overlaps the  E site  of the smal ribosomal subunit.  Based  on the extensive  overlap  of 
domain II  of  EF-P  with the  position  of an  E-site tRNA  on the smal subunit,  EF-P 
binding is predicted to preclude binding of tRNA to the E site. 
Although eIF5A lacks a structure coresponding to domain II of EF-P, it can be 
proposed that eIF5A binds to a similar region on the 80S ribosome. Accordingly, eIF5A 
would be positioned adjacent to the P-site tRNA and would overlap the ribosomal E site 
with the N-terminal domain of eIF5A lying close to the acceptor stem of the P-site tRNA. 
Interestingly, the  Arg32 residue  of T. thermophilus EF-P coresponds to  Lys51  of S. 
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synthesized in cels  depleted  of spermidine (Murphey and  Gerner,  1987; Park,  1987). 
Moreover, hypusine formation in eIF5A appeared to be constitutive with no evidence of 
turnover or reversion of the protein to the unmodified state (Duncan and Hershey, 1986; 
Gordon et al.,  1987b). Interestingly, in spermidine-dependent  mutants  of  yeast, the 
hypusine  modification  of eIF5A appeared to  be limiting for cel  growth, indicating that 
hypusine formation is a critical role of spermidine in cels (Chatopadhyay et al., 2008). 
Hypusine  biosynthesis is tightly controled  by two enzymes: deoxyhypusine 
synthase (DHS) and deoxyhypusine  hydroxylase (DOHH) (Fig.  5A).  First,  DHS 
catalyzes the transfer of an N -butylamine group from spermidine to the ε-amino group of 
the conserved lysine  on eIF5A (Lys50 in  human eIF5A and  Lys51 in  yeast) to form 
deoxyhypusine. In a second step, DOHH converts the deoxyhypusine residue to hypusine 
by addition of a hydroxyl group (Park et al., 1981; Park et al., 2010) (Fig. 5A). This later 
step involves a stereo-specific  hydroxylation at  C2  of the N-butylamine residue  of 
deoxyhypusine (N
ε
-(butylamine)lysine) to form  hypusine (N
ε
-(4-amino-2-
hydroxybutyl)lysine) (Abbruzzese et al.,  1986; Park et al.,  2006).  Both  genetic and 
biochemical studies  demonstrated that the  hypusine  modification is critical for eIF5A 
function. While  wild-type  yeast  or  human eIF5A can complement a lethal eIF5A 
knockout in  yeast, a conservative  mutation that substituted  Arg for  Lys at the site  of 
hypusination  blocked the ability  of  yeast  or  human eIF5A to complement the lethal 
phenotype of a yeast mutant lacking eIF5A (Magdolen et al., 1994; Schnier et al., 1991). 
Consistent with these in vivo results, unmodified forms of eIF5A that were produced in 
bacteria or purified from a chinese hamster ovary (CHO) cel line grown in the presence 
	  
	   17 
of 2-difluoromethylornithine, an inhibitor of spermidine biosynthesis, failed to stimulate 
Met-Pmn synthesis in vitro (Park, 1989; Park et al., 1991; Smit-McBride et al., 1989b). 
 
 
Figure 5. Post-translational modification pathways for eIF5A and EF-P. 
(A) In eukaryotes and archaea, an N-butylamine moiety is transfered from spermidine to 
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yeast)  by the enzyme DHS.  Next, DOHH adds a  hydroxyl  group to convert 
deoxyhypusine to hypusine.  
(B) In  bacteria, β-lysinylation  of  EF-P  occurs in two  known steps catalyzed  by  YjeK 
(EpmB) and YjeA/PoxA (EpmA). First, YjeK, a lysine aminomutase, converts lysine to 
β-lysine.  Next,  YjeA/PoxA catalyzes the addition  of β-lysine  onto the specific lysine 
residue (Lys34 on E. coli EF-P). It was controversial whether the EF-P post-translational 
β-lysinylation pathway produces a  ~128 or a ~144 Da modification. 
 
In contrast to the lack  of function  of  unmodified eIF5A, the partialy  modified 
deoxyhypusine form  of eIF5A is functional.  Purified  DHS  was readily able to add 
deoxyhypusine to recombinant eIF5A, but not to recombinant eIF5A-K51R (Park et al., 
1991), indicating that Arg is not an acceptor for deoxyhypusine and consistent with the 
failure  of the  K51R  mutant to function in vivo.  The deoxyhypusinated recombinant 
eIF5A stimulated  Met-Pmn synthesis, though  not as robustly as  native eIF5A  purified 
from  HeLa cels (Park et al.,  1991). While this result could  have indicated that ful 
hypusine  modification  was required for eIF5A function,  more recent experiments  using 
recombinant eIF5A  produced in  bacteria co-expressing  DHS  or  DHS  plus  DOHH 
revealed nearly equivalent abilities of the deoxyhypusine and hypusine forms of eIF5A to 
stimulate Met-Pmn synthesis (Park et al., 2011). Consistent with this later result, it was 
noteworthy that  yeast strains lacking the LIA1 gene encoding  yeast  DOHH  were  viable 
and grow only slightly slower than wild-type strains (Park et al., 2006; Park, 2006). 
The enzymes for  hypusine synthesis,  DHS and  DOHH, are conserved in 
eukaryotes and show  high specificity for eIF5A (Park et al.,  1997). The  DHS enzyme 
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from yeast was identified based on the sequence of tryptic peptides from purified rat DHS 
(Kang et al., 1995). The cloned DYS1 gene in yeast encodes a protein of 387 amino acids 
that  possesses  DHS activity, and  biochemical studies revealed  yeast  DHS to  be a 
homotetramer  of the  ~43  kDa subunits (Kang et al.,  1995). Consistent  with the 
deoxyhypusine requirement for eIF5A stimulation of Met-Pmn and peptide synthesis, and 
with the inability of eIF5A-K51R to function in vivo, the DYS1 gene is essential for yeast 
viability (Park et al.,  1998; Sasaki et al.,  1996).  Deoxyhypusine synthesis  proceeds 
through a  multistep  process including spermidine cleavage, a  DHS-imine intermediate, 
and then transfer  of the N-butylamine  moiety from the enzyme to eIF5A (Wolf et al., 
1997; Wolf et al.,  1995; Wolf et al.,  1990). Interestingly, the  DHS reaction required 
NAD (Chen and  Dou,  1988; Wolf et al.,  1990), and the  NAD cofactor as  wel as N1-
guanyl-1,7-diaminoheptane (GC7), a spermidine analog and inhibitor  of  DHS,  were 
observed in crystal structures of human DHS (Liao et al., 1998; Umland et al., 2004). 
Yeast  DOHH  was initialy identified  based  on its interaction  with eIF5A in a 
yeast two-hybrid assay (Thompson et al., 2003). The protein was named LIA1 to signify 
that it was a LIgand of eIF5A. Subsequently, Park and coleagues screened a yeast GST-
open reading frame (ORF) expression library for  DOHH activity and identified  LIA1 
(Park et al.,  2006). Consistent  with this  biochemical assignment,  deletion  of the LIA1 
gene  blocked the  production  of  hypusine,  but  not  deoxyhypusine in  yeast (Park et al., 
2006). Sequence analysis of the DOHH enzyme suggests that the 325 amino acid protein 
contains eight HEAT repeats with conserved His-Glu motifs present in four of the repeats 
(Park et al., 2006). DOHH contains 2 molecules of iron, thought to be present in a diron 
active site, per enzyme (Kim et al., 2006), and mutation of the conserved His-Glu motifs 
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impaired Fe and/or eIF5A binding to DOHH (Kang et al., 2007). In contrast to the non-
essential nature of DOHH in budding and fission yeast (Park et al., 2006; Weir and Yafe, 
2004), loss of DOHH is recessively lethal in C. elegans (Sugimoto, 2004) and Drosophila 
(Patel et al.,  2009), suggesting  perhaps that the  hydroxyl  group  on hypusine is  more 
critical for eIF5A function in metazoan cels. While the function of the hydroxyl group 
on hypusine is unknown, it is noteworthy that the yield of hypusinated (Hyp)-eIF5A in 
bacteria co-expressing eIF5A,  DHS and  DOHH is  greater than the  yield  of 
deoxyhypusinated (dHyp)-eIF5A in bacteria co-expressing eIF5A and DHS (Park et al., 
2011). As the  DHS reaction is reversible in vitro (Park et al.,  2003), it is  possible that 
hydroxylation of deoxyhypusine to hypusine blocks this back reaction and thus stabilizes 
the  hypusine  modification. Interestingly,  DOHH  orthologs  have  not  been identified in 
archaea (Park et al.,  2006). This lack  of  DOHH  was consistent  with the  presence  of 
deoxyhypusine rather than hypusine in some archaea (Bartig et al., 1990). Moreover, the 
presence  of  hypusine in a few archaeal species that  grew in the absence  of  oxygen 
indicated that a  distinct  mechanism  of  hydroxylation  has  been adopted (Bartig et al., 
1990). 
Genetic and  biochemical studies  have  provided insights into the recognition  of 
eIF5A by DHS and DOHH. In vitro assays with purified DHS and truncated derivatives 
of  human eIF5A identified the fragment from residues  10-90 as the smalest eficient 
substrate, while the highly conserved region consisting of residues Phe30 to Asp80 was the 
minimal fragment required for  deoxyhypusine  biosynthesis (Joe and  Park,  1994).  Point 
mutations in the conserved  hypusine loop sequence  G-Hyp-H-G-H-K immediately 
flanking the site  of  hypusine formation impaired  DHS  modification  of  human  or  yeast 
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eIF5A expressed in  yeast cels (Cano et al.,  2008; Dias et al.,  2008).  Taken together, 
these results indicated that DHS recognizes the N-terminal domain and residues flanking 
the modified Lys residue when forming hypusine on eIF5A. The DOHH recognition of 
dHyp-eIF5A is likewise mediated through the N-terminal domain of eIF5A. Residues 20-
90 of eIF5A were suficient for binding to DOHH and for hydroxylation in vitro (Kang et 
al.,  2007); and similar to the requirements for  deoxyhypusine synthesis,  mutation  of 
Lys47 and  His51 flanking the  Lys50 site  of  modification impaired  hydroxylation  of 
human eIF5A expressed in  yeast (Cano et al.,  2008).  Thus,  modification  of eIF5A  by 
both DHS and DOHH is dependent on recognition of the N-terminal domain of the factor 
and specific residues within the hypusine loop. 
Despite evidence supporting the essential nature of the eIF5A Lys residue that is 
modified to  hypusine, the  precise function  of  hypusine in  protein synthesis remains 
unknown. As stated above, Arg cannot substitute for the modified Lys residue in eIF5A; 
however,  partialy  modified eIF5A containing  deoxyhypusine retained the ability to 
stimulate  Met-Pmn synthesis (Park,  1989) and  maintained  yeast  viability (Park et al., 
2006). Interestingly, a structural mimic of eIF5A containing homodeoxyhypusine [N
ε
-(5-
aminopentyl)lysine]  was  unable to stimulate  Met-Pmn synthesis (Park et al.,  1991). In 
contrast to  hypusine,  which contains an N-butylamine  group from spermidine, 
homodeoxyhypusine contains an aminopentyl  moiety from N-(3-aminopropyl)-
cadaverine (Park et al., 1991). Thus, the side chain of homodeoxyhypusine is one methyl 
group longer than the side chain of hypusine. The observation that homodeoxyhypusine-
modified eIF5A  was  unable to stimulate  Met-Pmn synthesis indicated a  precise length 
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and structural restriction on the hypusine side chain, perhaps reflecting a critical contact 
between hypusine and other components in the eukaryotic translation complex. 
 
1.4.2 Phosphorylation of eIF5A 
In addition to its  hypusine  modification,  yeast eIF5A is also  phosphorylated.  The 
phosphorylation  was  mapped to the  Ser2 residue  of the  protein (Klier et al.,  1993). As 
mutation  of this residue to  Ala  did  not afect  yeast cel  growth and the  phosphorylated 
and  unphosphorylated forms  of the factor  were equaly active in stimulating  Met-Pmn 
synthesis in assays with mammalian factors and ribosomes, the phosphorylation of eIF5A, 
unlike its hypusine modification, did not appear to be important for the factor’s function 
(Kang et al., 1993; Klier et al., 1993). 
 
1.4.3 β-lysinylation (lysylation) of EF-P 
Alignment  of the  EF-P sequence from E. coli with the sequence  of eIF5A showed 
conservation of the Lys residue that is modified to hypusine in eIF5A (Fig. 2). However, 
the absence of DHS and DOHH homologs in E. coli (Park et al., 2011), the absence of 
spermidine labeling  of  proteins in  bacteria, and the substitution  of this  Lys residue in 
E.coli EF-P by Arg in several bacteria including Thermus thermophilus led to the notion 
that EF-P was not modified like eIF5A. However, several studies demonstrated that EF-P, 
at least in some  bacteria, is  modified.  Mass spectrometry (MS) analyses  of tryptic 
peptides from  native  EF-P  purified from E. coli revealed that  Lys34  was  modified, and 
that the modification contributed an extra mass of ~144 Da (Aoki et al., 2008). Based on 
comparative genomics analyses including gene clustering and phylogenetic conservation, 
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it  was  hypothesized that the E. coli genes yjeA and yjeK, encoding a truncated lysyl-
tRNA synthetase-related protein and a protein related to lysine aminomutase, respectively, 
function in a  pathway to  modify  EF-P (Baily and  de  Crecy-Lagard,  2010).  Consistent 
with the hypothesis that these genes were acting in the same pathway, mutation of yjeA 
(also  known as poxA, genX, and epmA) and yjeK (epmB) in Salmonela enterica had 
equivalent and  non-additive  negative impacts  on S. enterica virulence and resistance to 
antibiotics (Navare et al.,  2010).  Biochemical studies  demonstrated that  YjeA/PoxA 
could lysinylate (lysylate) EF-P in vitro (Navare et al., 2010; Yanagisawa et al., 2010), 
and this activity was dependent on the conserved Lys34 residue which coresponds to the 
site of hypusine modification in eIF5A (Navare et al., 2010). In vitro and co-expression 
studies revealed that YjeA/PoxA could add a Lys residue to EF-P, increasing the mass by 
~128  Da (Navare et al.,  2010; Yanagisawa et al.,  2010).  Notably, this  mass is  ~16  Da 
less than the ~144 Da modification detected by Aoki et al. (Aoki et al., 2008). In the co-
expression studies, enhanced levels of EF-P modification were observed in the presence 
of yjeK, encoding a homolog of lysine-2,3-aminomutase that catalyzed the isomerization 
of α-lysine to β-lysine, and it  was thus concluded that  EF-P is  modified to a β-lysyl-
lysine form (Yanagisawa et al., 2010) (Fig. 5B). Until now, it is not known whether EF-P 
is  modified in  bacterial species that lack  Lys at residue  34, such as T. thermophilus in 
which Lys34 is substituted by Arg. 
 
1.5 Yeast studies reveal a role for eIF5A in translation elongation 
Molecular genetic and biochemical studies of yeast eIF5A have provided novel insights 
into the function  of the factor.  Using the  human eIF5A cDNA in comparative 
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hybridization techniques, Schnier et al. identified two genes encoding eIF5A in the yeast 
Saccharomyces cerevisiae (Schnier et al.,  1991).  The  yeast  genes HYP2 and ANB1 
encode  157-residue  proteins that shared  90% amino acid sequence identity  with  one 
another and  >60% identity  with  human eIF5A (Schnier et al.,  1991) (Fig.  2). Though 
HYP2 and ANB1 difer  by  only  15 residues, it  was  not entirely clear  why  yeast retain 
these two isoforms.  Nevertheless, further studies  by several laboratories revealed that 
expression  of HYP2 and ANB1 was reciprocaly regulated  by  oxygen.  Whereas ANB1, 
also  known as HYP1 or TIF51B, is expressed exclusively  under anaerobic conditions, 
HYP2, also  known as TIF51A,  was  preferentialy expressed  under aerobic conditions 
(Lowry et al., 1983; Magdolen et al., 1994; Mehta et al., 1990; Schwelberger et al., 1993). 
Consistent with these expression paterns, HYP2 was essential for growth under aerobic 
conditions,  but  dispensable for anaerobic  growth (Schnier et al.,  1991; Schwelberger et 
al., 1993; Wohl et al., 1993). In contrast, ANB1 was dispensable for growth under aerobic 
conditions (Schnier et al.,  1991).  These  growth  phenotypes can be atributed to the 
expression  paterns  of HYP2 and ANB1 and  not to functional  diferences  between the 
protein isoforms, as expression of HYP2 or ANB1 protein from a heterologous promoter 
was able to restore  growth  of a  yeast strain lacking the HYP2 gene (Magdolen et al., 
1994; Schwelberger et al.,  1993; Wohl et al.,  1993).  Moreover, expression  of  human, 
alfalfa,  or slime  mold eIF5A  protein  was able to complement the  growth  defect in the 
strain lacking HYP2,  demonstrating the functional equivalence  of eIF5A across 
eukaryotes (Magdolen et al., 1994; Schwelberger et al., 1993; Wohl et al., 1993). 
To  gain further insights into eIF5A function, several  groups  have examined the 
impact of depleting eIF5A in yeast. By placing HYP2 expression under the control of a 
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galactose-regulated  promoter, eIF5A expression  was turned  of  by changing  growth 
conditions. In initial experiments, depletion of eIF5A resulted in a significant inhibition 
of cel growth but only a 30% reduction in total protein synthesis rates, as measured by 
[35S]Met incorporation, and a smal change in  polysome  profiles (Kang and  Hershey, 
1994). This  discrepancy  between the impact  of eIF5A  depletion  on cel  growth  versus 
protein synthesis raised the possibility that eIF5A was required for the translation of only 
a subset of mRNAs whose protein products were critical for cel growth. Further studies 
with the same eIF5A  degron revealed a  more substantial impairment in  general 
translation  with  up to a  4-fold  decrease in translation rates  upon  depletion  of eIF5A in 
rich medium (Henderson and Hershey, 2011). Consistent with this later study, analysis 
of an independent eIF5A degron revealed a pronounced defect in total protein synthesis 
upon  depletion  of eIF5A (Saini et al.,  2009).  Likewise, total  protein synthesis  was 
impaired when an eIF5A temperature-sensitive (ts-) mutant was shifted to the restrictive 
temperature (Dias et al., 2008). 
While these eIF5A degron studies revealed that eIF5A promotes general protein 
synthesis, the role of the factor in translation was not resolved. Polysome profile analyses 
are commonly  used to assess translation function in  yeast. In this technique, cels  were 
treated  with cycloheximide (CHX) to freeze  ongoing translation elongation and crude 
extracts were fractionated on sucrose gradients. While one study reported a loss of larger 
polysomes and accumulation  of smaler  polysomal species and  80S  monosomes  upon 
depletion of eIF5A, indicative of a translation initiation defect (Henderson and Hershey, 
2011), this  polysome loss  was  not  detected in  other studies.  Zaneli et al. reported that 
polysomes  were  maintained  upon shifting two  diferent eIF5A ts- mutants to the 
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restrictive temperature (Zaneli et al., 2006). Moreover, polysome analyses performed by 
Saini and co-workers indicated a  defect in translation elongation  upon  depletion  or 
inactivation of eIF5A (Saini et al., 2009). Whereas omission of CHX during analysis of 
strains expressing  wild-type eIF5A resulted in the expected loss  of  polysomes  due to 
continued translation elongation and release  of the ribosomes from  mRNAs  during 
extract preparation, polysomes were maintained in the absence of CHX upon depletion of 
eIF5A (Saini et al.,  2009).  This retention  of  polysomes in the absence  of CHX in the 
eIF5A mutant mimicked the efect of CHX addition to the wild-type strain. Thus loss of 
eIF5A, like addition of CHX, impaired translation elongation. 
Though the extended incubations required to fuly  deplete eIF5A in the  degron 
strains might have alowed secondary efects resulting in the apparent elongation defect, 
similar polysome retention in the absence of CHX was observed in an eIF5A ts- mutant 
after shifting for a short time to the restrictive temperature (Saini et al.,  2009). 
Interestingly, polysome analyses in Drosophila and mammalian cels likewise indicated a 
role for eIF5A in translation elongation. Knockdown of eIF5A expression in Drosophila 
S2 cels resulted in the accumulation  of  polysomes (Patel et al.,  2009), and  whereas 
treatment  of  mammalian cels  with arsenite caused impaired translation initiation and 
polysome loss,  knockdown  of eIF5A  was reported to  block this  disassembly  of 
polysomes in arsenite-treated cels (Li et al., 2010). In further support of the notion that 
loss  or inactivation  of eIF5A impaired translation elongation, two studies reported that 
eIF5A  mutations caused an increase in the average ribosomal transit time, the time it 
takes for a ribosome folowing initiation to synthesize and release a completed 
polypeptide (Gregio et al.,  2009; Saini et al.,  2009). It is  noteworthy that  both the 
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polysome  profile analyses and ribosomal transit time  measurements assessed  global 
translation. Thus, these data indicate that loss of eIF5A impairs translation elongation on 
a substantial fraction of the mRNAs in yeast cels.  
Consistent  with the results  of the  yeast  genetic studies, in vitro assays  have 
provided additional evidence that directly link yeast eIF5A to translation elongation. First, 
the translation defect in crude extracts prepared from eIF5A-depleted or mutant extracts 
was rescued by addition of purified eIF5A in a hypusine-dependent manner (Henderson 
and Hershey, 2011; Saini et al., 2009). Hyp-eIF5A, and not the unmodified eIF5A-K51R 
mutant, stimulated the rate of Met-Phe-Phe (M-F-F) tripeptide synthesis in reconstituted 
in vitro translation assays employing recombinant  or  highly  purified translation factors 
and ribosomes (Saini et al.,  2009). In further support  of these studies that  directly link 
eIF5A to translation elongation, other reports indicate eIF5A association with ribosomes 
or polysomes in whole-cel extracts (WCEs) from yeast (Jao and Chen, 2006; Saini et al., 
2009; Zaneli et al., 2006) and are consistent with earlier studies of an eIF5A mutant that 
suppresses nonsense-mediated mRNA decay (Zuk and Jacobson, 1998). Taken together, 
the results of these various in vivo and in vitro studies indicate that eIF5A is a translation 
elongation factor. 
 
1.6 Thesis research objectives and significance of findings 
 After  nearly  40  years  of  genetic and  biochemical  work, eIF5A  has  heretofore 
remained an enigma. However, based upon previous work atributing a role for eIF5A in 
translation elongation (Saini et al.,  2009; Zaneli et al.,  2006) and the structure  of 
bacterial  EF-P  bound to  70S ribosomes,  which  places the  hypusine loop in close 
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proximity to the CCA acceptor stem of the P-site tRNA (Blaha et al., 2009), eIF5A/EF-P, 
at the time that I joined the lab, was poised for new functional and mechanistic insights 
into its role in translation. Given the substantial promise for new eIF5A discoveries, the 
primary focus of my thesis research was to delineate the requirements for eIF5A and its 
hypusine  modification in  protein synthesis. We hypothesized that eIF5A  bound the 
ribosome and functioned to  present  hypusine to the ribosome active site to  promote 
peptide bond formation. Combining yeast genetics, biochemistry, and ribosome profiling 
techniques,  we  uncovered a specialized role for eIF5A in  promoting the translation  of 
polyproline  motifs, and also  defined the requirements for hydroxylation of  hypusine as 
mediated  by LIA1.  Ultimately,  our  data reinforce the critical function  of eIF5A in 
translation elongation and reveal a specialized role for incorporation  of specific amino 
acids in proteins. 
 First, we explored the possibility that eIF5A promotes amino acid-specific peptide 
bond synthesis. We initialy proposed that eIF5A may have a function similar to reports 
made  by  Glick et al., who  demonstrated in vitro that  EF-P stimulated  peptide  bond 
formation  of  particular amino acid  dipeptides (Glick et al.,  1979).  Concurent with my 
studies  on eIF5A impacts  on synthesis  of  proteins containing  homopolymeric runs  of 
specific amino acids, Ude and coleagues (Ude et al., 2013) and Doerfel and co-workers 
(Doerfel et al.,  2013) reported that E. coli EF-P enhanced the synthesis  of  proteins 
containing runs  of consecutive  proline codons.  Given this finding, I focused my eforts 
on asking whether eIF5A had a similar function in eukaryotic cels. 
 In colaboration  with other members  of the  Dever lab and  with  Chris 
Woolstenhulme and Alen Buskirk of Brigham Young University, we used in vivo assays 
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in yeast and in vitro reconstituted translation assays to reveal a specific requirement for 
eIF5A to  promote  peptide  bond formation  between consecutive  proline residues.  We 
found that addition  of eIF5A relieves ribosomal staling  during translation  of three 
consecutive  proline residues in vitro, and loss  of eIF5A function impairs translation  of 
polyproline-containing  proteins in vivo.  Moreover, in colaboration  with the  Rachel 
Green lab at Johns  Hopkins  Medical Institute, results from genome-wide ribosome 
profiling studies revealed ribosomal pausing and/or  drop-of  during translation  of 
consecutive  proline residues.  Thus, we  proposed that eIF5A, like its  bacterial  ortholog 
EF-P, functions to  promote the peptidyl transferase activity  of the ribosome and 
facilitates the reactivity of poor substrates like proline during peptide bind formation. 
 To investigate the functional role of hypusine and its hydroxyl group, I identified 
a distinct class of eIF5A mutants that require LIA1 for eficient cel growth. Using a yeast 
genetic screen, I found a colection  of eIF5A  mutants that elicit synthetic  phenotypes 
when  deoxyhypusine is  unable to  mature to  hypusine. I identified three eIF5A  mutants 
eIF5A-C23Y,V60D, eIF5A-S74F, and eIF5A-N79I that modestly impact cel growth on 
their  own,  but that are severely impaired  or inviable in the absence  of LIA1.  Another 
mutant, eIF5A-H52A, identified in a candidate-based screen  by  mutational analysis  of 
residues surounding the hypusine modification, also showed exacerbated phenotypes in 
the absence  of LIA1.  As the  mutant  proteins  were expressed wel in the absence  or 
presence of LIA1, and loss of LIA1 did not result in accumulation of unmodified eIF5A 
versus the deoxyhypusine form, we concluded that the hydroxyl group on hypusine does 
not function to prevent the back reaction of the deoxyhypusine-containing to unmodified 
form of the eIF5A mutants. Using reconstituted yeast translation assays, I found that the 
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dHyp forms  of these eIF5A  mutants  were  defective in synthesis  of a  polyproline-
containing peptide. Thus, analysis of these mutants has revealed that the hydroxyl group 
on hypusine has a direct role in promoting protein synthesis. Altogether, our research has 
provided new insights into the functional requirements of the hypusine modification on 
eIF5A and established its role in translation elongation and specificaly in promoting the 
translation of polyproline motifs. 
  
	  











2. Materials and Methods 
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2.1 Yeast strains 
Strain Description Source 
H1511  MATα ura3-52 leu2-3 leu2-112 trp1-Δ63 (Foiani et al., 1991) 
J696 MATα trp1-Δ63 ura3-52 leu2-3 leu2-112 gcn2Δ (Saini et al., 2009) 
 anb1:NAT hyp2:KANMX4 p[HYP2, URA3] 
J697 MATα trp1-Δ63 ura3-52 leu2-3 leu2-112 gcn2Δ (Saini et al., 2009) 
 anb1:NAT hyp2:KANMX4 p[HYP2, LEU2]  
J699  MATα trp1-Δ63 ura3-52 leu2-3 leu2-112 gcn2Δ (Saini et al., 2009) 
 anb1:NAT hyp2:KANMX4  
 p[hyp2-S149P, LEU2]  
J1005 MATa trp1-Δ63 ura3-52 leu2-3 leu2-112 GAL2+ This study  
 gcn2Δ hyp2:HPHMX4 anb1:NAT 
 p[HYP2, URA3] 
J1058 MATa trp1-Δ63 ura3-52 leu2-3 leu2-112 GAL2+ This study  
 gcn2Δ hyp2:HPHMX anb1:NAT 
 GAL-LIA1:KANMX4 p[HYP2, URA3] 
J1119 MATa trp1-Δ63 ura3-52 leu2-3 leu2-112 GAL2+ This study  
 gcn2Δ hyp2:HPHMX anb1:NAT lia1:KANMX4 
 p[HYP2, URA3] 
TKY597 MATα leu2-3 leu2-112 ura3-52 trp1-7 yef3:LEU2  (Anand et al., 2003) 
  lys2 his4-713 met2-1 p[YEF3, TRP1]     
TKY599 MATα leu2-3 leu2-112 ura3-52 trp1-7 yef3:LEU2  (Anand et al., 2003) 
  lys2 his4-713 met2-1 p[yef3-F650S, TRP1]    
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TKY675 MATa ade2 leu2 ura3 his3 trp1 eft1:HIS3 (Jorgensen et al., 2002) 
  eft2:TRP1 p[EFT2-6xHis, LEU2]  
TKY702 MATα leu2-3 leu2-112 ura3-52 trp1-7 yef3:LEU2 (Anand et al., 2003) 
  lys2 his4-713 met2-1 p[YEF3-6xHis, TRP1]    
TKY742 MATa ade2 leu2 ura3 his3 trp1 eft1:HIS3  (Ortiz et al., 2006) 
 eft2:TRP1 p[eft2-6xHis-H699N, LEU2]     
TKY825 MATa ade2 leu2 ura3 his3 trp1 eft1:HIS3 (Ortiz et al., 2006) 
 eft2:TRP1 p[eft2-6xHis-H696A, LEU2]  
YRP840 MATa leu2-3 leu2-112 his4-539 trp1 ura3-52  (Hatfield et al.,  1996)
 cup1:LEU2/PGK1pG/MFA2pG 
 
2.2 Polysome analysis 
Yeast cultures were either treated with 50 µg/mL CHX for 5 min before colection or left 
untreated, transfered to a 500 mL centrifuge botle containing shaved ice, peleted, and 
washed with 10 mL Bufer A (20 mM Tris-HCl [pH 7.5], 50 mM KCl, 10 mM MgCl2, 1 
mM DTT, Complete protease inhibitor cocktail [EDTA-free, Roche]). In al subsequent 
steps, the  CHX-treated cels  were treated  with  50 µg/mL CHX.  Cel  pelets  were 
suspended in 300-500 µL Bufer A, mixed with an equal volume of glass beads, and then 
cels  were  broken  by  5 cycles  of  vigorous  mixing  on a  vortex for  1  min folowed  by  1 
min on ice. Folowing clarification, ten OD254 units of the WCE were layered on 4.5-45% 
sucrose  gradients  prepared in Bufer  A, and then subjected to centrifugation in a 
Beckman SW41 rotor for 2.5 h at 260,000 × g. Gradients were fractionated on a Teledyne 
ISCO Density Gradient Fractionator while monitoring absorbance at OD254. 
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2.3 Plasmid and yeast strain construction 
Yeast strain J1005  was constructed  by swapping a  hygromycin-resistance (HPHMX4 R) 
cassete in place of a kanamycin-resistance (KANMX4 R) cassete in the yeast strain J696 
as  described  previously (Goldstein and  McCusker,  1999).  First,  plasmid  pAG32 
containing the HPHMX4R cassete  was  digested  with BamHI and SpeI [Roche].  The 
digested plasmid was PCR-purified, then transformed into J696 using the lithium acetate 
procedure (Gietz et al., 1995). Yeast cels were alowed to recover in 1 mL yeast peptone 
dextrose (YPD) for  90  min at  30°C  while shaking, then  plated  on  YPD containing  0.5 
µg/mL hygromycin.  Those colonies that  grew in the  presence  of  hygromycin  were 
streaked  on  YPD plates. Individual colonies  were  patched and prepared for replica 
printing to confirm the  markers.  Colonies that  grew in the  presence  of  hygromycin 
(Hph+) and nourseothricin (Nat+) due to the presence of anb1:NAT alele, but failed to 
grow  on  medium containing  kanamycin (Kan-),  were checked  by  PCR for the  gain  of 
HPHR cassete, retention of NATR cassete, and loss of KANR cassete. 
Using the  parent  yeast strain J1005, strain J1058  was constructed  by inserting a 
galactose-inducible  promoter  upstream  of the chromosomal LIA1 gene.  First, a  DNA 
fragment containing the inducible GAL1 promoter and an upstream kanamycin selectable 
marker was amplified by PCR using the plasmid pFA6a-KANMX6-PGAL1 (Longtine et 
al., 1998) as a template. The PCR amplification was conducted using primers that contain 
50 nucleotide complementarity to the promoter (P1) or start of the LIA1 ORF (P2) and 20 
nucleotide complementarity to the plasmid: 
P1 5’-AATCCAGTGAATACACGTGTATATTTGACGGTAGGTTTAGGTTAGA-
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3’ (forward) 
P2 5’-AGAGTGCATTCATCGACGTTTTCTTGGAAATGTTTTTCAAAGTTAGT 
 AGACATTTTGAGATCCGGGTTTT-3’ (reverse) 
The PCR product was gel-purified and used to transform J1005 using the lithium acetate 
procedure (Gietz et al., 1995). Cels were plated on YPD containing G418 to select for 
the KANMX6R cassete.  Those colonies that grew in the  presence of G418  were 
kanamycin resistant (Kan+) and were streaked on YPD. Individual colonies were patched 
and prepared for replica printing to check the markers. Colonies displaying hygromycin 
resistance (Hph+),  nourseothricin resistance (Nat+), and  kanamycin resistance (Kan+) 
were checked by PCR for the presence of the HPHR cassete, the NATR cassete, and the 
KANR cassete. Expression of GAL-LIA1 in galactose-containing medium and repression 
of GAL-LIA1 in glucose-containing medium was checked by RT-PCR. 
 Strain J1119 was constructed by deletion of the chromosomal copy of LIA1 and 
replacement with a KANMX4R cassete in strain J1005. Using the primers 
P3 5’-AGAACAAAAGGTGAGGTCAACGAGAACTCTG-3’ (forward) 
P4 5’-GCACCTGGTAGACCGTTAAATTCGTCAAATC-3’ (reverse), 
which are complementary to sequences 500 bp 5’ and 500 bp 3’, respectively, of the LIA1 
locus, the lia1Δ:KANMX4R cassete  was amplified  using chromosomal  DNA from the 
lia1Δ strain from the  Yeast  ORF  deletion colection [Open  Biosystems] as a template. 
The  PCR  product  was  used to transform strain J1005, selecting for Kan+ colonies. 
Candidate transformants  were tested for  hygromycin (Hph+) and  nourseothricin (Nat+) 
resistance  by replica test, and the replacement  of LIA1 by lia1Δ:KANMX4 was 
confirmed by PCR.  
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 To construct a HYP2 mutant library, eror-prone PCR using a low-fidelity DNA 
polymerase [Agilent Tecnologies]  was  used to amplify the HYP2 gene in  plasmid 





The  PCR  product  was  purified and sub-cloned  between the EagI and XhoI sites in the 
plasmid pC3292 (Saini et al., 2009). The ligation products were transformed into E.coli 
by electroporation and approximately  10,000 independent colonies  were colected.  The 
HYP2 mutant plasmid library was amplified by inoculating the pooled colonies into LB + 
ampicilin medium, and the plasmids were isolated using a Qiagen Midiprep kit. 
Site-directed  mutagenesis  of the HYP2 gene  was  performed  using the 
QuikChange I  XL  kit [Stratagene].  The folowing  primers  were  used to introduce the 
point mutations: 
C23Y 
P7 5’-CCACCTACCCAATGCAATATTCTGCCTTGAGAAAGA-3’ (forward) 
P8 5’-TCTTTCTCAAGGCAGAATATTGCATTGGGTAGGTGG-3’ (reverse) 
V60D 
P9 5’-CACGCTAAAGTCCATTTGGATGCCATTGATATCTTCACT-3’ (forward) 









P13 5’-GTCTCCATCTACTCACATCATGGAAGTTCCAGTTG-3’ (forward) 







P17 5’-GAAGAAGCCGCCATCCCCTTCAAGGAAGCTG-3’ (forward) 
P18 5’-CAGCTTCCTTGAAGGGGATGGCGGCTTCTTC-3’ (reverse) 
 The HYP2 mutant  plasmids,  which  bear a LEU2 selectable  marker,  were 
substituted in  place  of the  wild-type HYP2,URA3 plasmid in hyp2Δ strains  by  plasmid 
shufling (Boeke et al., 1987). 
 
2.4 Dual luciferase assay 
Dual luciferase reporter constructs containing 10 codon repeats at amino acid  314 
between the in-frame Renila and firefly luciferase ORFs were  obtained from Beth 
Grayhack (Letzring et al., 2010). Constructs with insertions of variable numbers of Pro or 
Phe codons  between the two luciferase  ORFs  were  generated  by cloning  PCR  products 
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between the  unique SalI, located  prior the insert, and PstI, located after the firefly 
luciferase ORF, restriction sites of the parental dual luciferase plasmid pDL202: 
 
The folowing primers were used to introduce the consecutive Pro or Phe codons: 
Single Pro Insert 
P19 5’-CCCCCCGTCGACGCCATTCGGATCCTTCAACTTCCCTGAGCTCGA-3’ 
(forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Single Phe Insert 
P21 5’-CCCCCCGTCGACGTTCTTCGGATCCTTCAACTTCCCTGAGCTCGA-3’ 
(forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Two Pro Insert 
P22 5’-CCCCCCGTCGACGCCACCATTCGGATCCTTCAACTTCCCTGAGCTC 
GA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Two Phe Insert 
P23 5’-CCCCCCGTCGACGTTCTTCTTCGGATCCTTCAACTTCCCTGAGCTCG 
A-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Three Pro Insert 
Expressed from a YEplac195 (URA) based vector [Gene 74(2): 527-534 (1988)]; NCBI accession # X75459 
 
Renila and Firefly genes were subcloned from p2luc [RNA 4(4): 479-486 (1998)]; NCBI accession # AF043450 
 































- Pst1-Xho1-Sph1 - 
Readthrough cassete: 
 
ATG TCG ACG TGC GAT XXX NCG TTC GGA TCC 
 M    S    T    C    D   Q/R   T    F    G    S 
          P 
                    A 
                    S 
Sal1 BamH1 
Yeast Dual Luciferase Reporter Constructs 
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P24 5’-CCCCCCGTCGACGCCACCACCATTCGGATCCTTCAACTTCCCTGAG 
CTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Three Phe Insert 
P25 5’-CCCCCCGTCGACGTTCTTCTTCTTCGGATCCTTCAACTTCCCTGAGC 
TCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Four Pro Insert 
P26 5’-CCCCCCGTCGACGCCACCACCACCATTCGGATCCTTCAACTTCCCT 
GAGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Four Phe Insert 
P27 5’-CCCCCCGTCGACGTTCTTCTTCTTCTTCGGATCCTTCAACTTCCCTG 
AGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Six Pro Insert 
P28 5’-CCCCCCGTCGACGCCACCACCACCACCACCATTCGGATCCTTCAA 
CTTCCCTGAGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Six Phe Insert 
P29 5’-CCCCCCGTCGACGTTCTTCTTCTTCTTCTTCTTCGGATCCTTCAACT 
TCCCTGAGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
	  
	   40 
Eight Pro Insert 
P30 5’-CCCCCCGTCGACGCCACCACCACCACCACCACCACCATTCGGATC 
CTTCAACTTCCCTGAGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Eight Phe Insert 
P31 5’-CCCCCCGTCGACGTTCTTCTTCTTCTTCTTCTTCTTCTTCGGATCC 
TTCAACTTCCCTGAGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Ten Pro Insert 
P32 5’-CCCCCCGTCGACGCCACCACCACCACCACCACCACCACCACCATT 
CGGATCCTTCAACTTCCCTGAGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
Ten Phe Insert 
P33 5’-CCCCCCGTCGACGTTCTTCTTCTTCTTCTTCTTCTTCTTCTTCTTC 
GGATCCTTCAACTTCCCTGAGCTCGA-3’ (forward) 
P20 5’-CGAAAAGCTTGCATGCCTCGAGCTGCAGGCG-3’ (reverse) 
To  measure luciferase activities, individual  yeast transformants  were  grown in 
Synthetic  Dextrose (SD) medium containing required  nutrients to  OD600 =  0.8-1.0, 
harvested, and the cel  pelets  were resuspended in  300 µL Breaking  Bufer  L (20  mM 
Tris-HCl [pH  7.5],  100  mM  KCl,  5  mM  MgCl2,  0.1  mM  EDTA,  Complete protease 
inhibitor cocktail [EDTA-free, Roche]), and vigorously mixed with 1 vol glass beads on a 
vortex for 1 min at 4°C. Lysates were cleared by centrifugation at 9,400 × g for 5 min at 
4°C, and aliquots  of the supernatant  were assayed for firefly luciferase activity  using a 
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microplate luminometer [Berthold] and the Dual Luciferase Reporter 1000 Assay System 
[Promega]. Next, Renila luciferase activity was measured folowing addition of Stop and 
Glo reagent [Promega]. 
 The ratio  of firefly to Renila activity  was  measured for each  of the reporters 
tested and those  values  were  normalized to the firefly to Renila ratio for the  no insert 
control (pDL202),  which  was  pre-set to a  value  of  1.0.  For eror calculations, the 






















where R is the average of the reporter firefly to Renila ratio over the average of no insert 
firefly to Renila ratio, δX is the standard deviation of the reporter firefly to Renila ratio, 
X is the average of the reporter firefly to Renila ratio, δY is the standard deviation of the 
no insert firefly to Renila ratio, Y is the average of the no insert firefly to Renila ratio. 
 
2.5 Peptide formation assay 
Initiation complexes were prepared in 1× Recon Bufer A (30 mM Hepes-KOH [pH 7.4], 
100 mM KCl, 2.5 mM magnesium acetate, 2 mM DTT) based on the protocol described 
by  Acker et al. (Acker et al.,  2007) and contained the folowing components:  4  nM 
[35S]Met-tRNAi
Met,  0.4  µM eIF2,  1  µM eIF1,  1  µM eIF1A,  0.4  µM  40S,  1  µM  mRNA 
(5’-AUGCCACCACCAAAAUAA-3’) encoding 5’-M-P-P-P-K-Stop-3’,  1  µM eIF5 and 
0.5  µM eIF5B.  Al reactions  were  performed at  26°C.  Folowing assembly  of initiation 
complexes, reactions were layered on 0.8 mL 1M sucrose cushion in 1× Recon Bufer A 
and then  peleted  by centrifugation at  260,000 × g for  1  h.  Ribosomal  pelets  were 
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dissolved in  1× Recon  Bufer  B (30  mM  Hepes-KOH [pH  7.4],  100  mM KCl,  1  mM 
magnesium acetate, 2 mM MgCl2,  1  mM spermidine,  2  mM DTT, and aliquots  were 
stored at -80°C. 
 Peptide formation assays contained 2 nM initiation complex, 2 µM eEF1A, 1 µM 
eEF2, 1 µM eEF3, 10 nM to 5 µM eIF5A, 1 µM Pro-tRNAProUGG, 1 µM Lys-tRNA
Lys
UUU, 
1  mM  GTP and  1  mM adenosine-5’-triphosphate (ATP) in  1× Recon  Bufer  B.  The 
elongation assay components  were  pre-incubated for  15  min  on ice  before adding the 
initiation complex, and then reactions  were incubated at  26°C.  Progress  of  peptide 
formation  was examined  by electrophoretic thin-layer chromatography (TLC) as 
described  previously (Eyler and  Green,  2011).  Briefly, elongation reactions  were 
quenched at diferent times by mixing with an equivalent vol of 0.2 N KOH to hydrolyze 
the peptidyl-tRNA product, and then 0.5 µL was spoted on a celulose TLC plate [EMD 
Chemicals]. The spot  was  dried  using a  heat  gun, then the  TLC  plate  was  briefly 
equilibrated with pyridine acetate bufer (200 mL glacial acetic acid and 5 mL pyridine in 
1 L,  pH  2.8)  before electrophoresis at  1,000  V for  20  min in the same  pyridine acetate 
bufer. Folowing electrophoresis, the TLC plate was dried using a heat gun, and peptide 
spots were detected by phosphorimage analysis. The fractional yield of the peptides and 
free [35S]Met in each reaction at  diferent times  were  quantified and fit  using 
KaleidaGraph [Synergy Software] to the single exponential equation: y = Ymax (1-exp (-
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2.6 Preparation of initiation and elongation factors 
Initiation factors eIF1 and eIF1A were expressed in E. coli BL21 CodonPlus (DE3)-RIL 
cels [Agilent Technologies] and purified using the IMPACT Protein Purification System 
[New  England  Biolabs] as  described  previously (Shin et al.,  2011). eIF5 was  kindly 
provided by Byung Shin and purified as in Shin et al. (Shin et al., 2011). Initiation factor 
eIF5B was purified from yeast using Glutathione Sepharose 4B afinity chromatography 
as described previously (Shin and Dever, 2007) with minor modification. Briefly, yeast 
strain  H1511  harboring the expression  vector  pEG-KT-eIF5B397-1002 (Shin and  Dever, 
2007) was  grown in  S-rafinose  medium (0.145%  yeast  nitrogen  base (YNB),  0.5% 
ammonium sulfate and  2% rafinose  plus required supplements)  until OD600 = 0.5, and 
GST-eIF5B397-1002 expression  was induced  by adding  galactose to final  2% (v/v) and 
incubating the culture  with shaking at  30°C for  14 h.  Cels  were  harvested and the cel 
pelet was suspended in an equivalent volume of Lysis Bufer A (1× phosphate-bufered 
saline (PBS) solution containing  Complete protease inhibitor cocktail [EDTA-free, 
Roche],  0.5 mM  4-(2-aminoethyl) benzenesulfonyl fluoride  hydrochloride (AEBSF), 
5 µg/mL pepstatin).  Cels  were  broken  by adding  50% (v/v)  glass  beads to the cel 
suspension and then mixing vigorously on a vortex for 5 min at 4°C. Folowing removal 
of the  glass  beads and  unbroken cels  by centrifugation at  1,900 × g for  10  min, the 
extract  was clarified  by centrifugation at  27,000 × g for  30 min, and then  mixed  with 
1 mL of a 50% slury of Glutathione Sepharose 4B [GE Healthcare] at 4°C for 2 h. The 
resin  was then  washed extensively  with  20-fold excess  volume  of  1× PBS  bufer, and 
eIF5B was eluted by adding 40 U/mL thrombin in 1× PBS bufer and incubating at room 
temperature for 2 h and then overnight at 4°C. The supernatant containing released eIF5B 
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was  dialyzed against  Storage  Bufer  A (20 mM Hepes-KOH [pH  7.5], 
100 mM potassium acetate, 2.5 mM magnesium acetate, 2 mM DTT, and 10% glycerol) 
and aliquots were stored at -80°C.  
 Elongation factor eEF1A was purified from YRP840 (Hatfield et al., 1996). Cels 
were grown in 2.5 L YPD to OD600 = 2.0, harvested, and broken in 150 mL Lysis Bufer 
B (60 mM Tris-HCl [pH 7.5], 50 mM KCl, 5 mM MgCl2, 0.1 M EDTA [pH 8.0], 10% 
glycerol,  1  mM  DTT,  0.2  M  AEBSF)  using  glass  beads as  described above.  After 
removal of unbroken cels by centrifugation at 7,600 × g for 30 min, the supernatant was 
clarified  by centrifugation at  150,000 × g for  3  h, and then  mixed  gently  with  10  mL 
DE52 resin (Whatman, pre-equilibrated with Lysis Bufer B) for 1 h at 4°C. The unbound 
fraction containing eEF1A  was isolated  by  pouring the  mixture into a column and 
colecting the elute,  which  was then applied to a  HiTrap  CM  Sepharose column (GE 
Healthcare), and eEF1A  was eluted  with a linear  gradient to  500  mM KCl.  Fractions 
containing eEF1A  were identified  by  SDS-PAGE,  pooled,  dialyzed against  Storage 
Bufer A and stored at -80°C.  
Poly-histidine tagged versions of elongation factors eEF2 and eEF3 were purified 
from  yeast strains  TKY675 and  TKY702, respectively,  using  published  protocols 
(Andersen et al., 2004; Ortiz et al., 2006) with some modifications. Cels were grown in 5 
L YPD to OD600 =  1.5,  harvested, and then suspended in  Lysis  Bufer  C (20  mM  Tris-
HCl [pH  7.6],  300  mM KCl,  1  mM  DTT,  1  mM  AEBSF,  10  mM imidazole, and  1× 
Complete  protease inhibitor cocktail [EDTA-free,  Roche]).  After the cels  were  broken 
with  glass  beads as  described above, the lysate  was cleared  of  unbroken cels  by 
centrifugation at 17,000 × g for 30 min, clarified by centrifugation at 180,000 × g for 80 
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min, and then gently mixed with 1 mL Ni-NTA resin for 2 h at 4°C. The resin was then 
washed  with  5  vol  of the  Lysis  Bufer  C containing  20  mM imidazole, and the  His6-
tagged  proteins  were eluted in  Bufer  E containing  500  mM imidazole. eEF2  or eEF3 
were identified by SDS-PAGE then concentrated and dialyzed against Storage Bufer B 
(20  mM  Tris-HCl [pH  7.5],  100  mM potassium acetate,  0.1  mM magnesium acetate,  2 
mM DTT, 10% glycerol) and then stored at -80°C.  
 
2.7 Preparation of wild-type and mutant eIF5A 
The  polycistronic expression system  developed  by  Song  Tan (Tan,  2001) was  used to 
produce unmodified or modified (dHyp or Hyp) forms of eIF5A in E. coli. As produced 
by Byung Shin and Joo-Ran Kim, an N-terminaly His6-tagged version of the HYP2 ORF 
was cloned between the NdeI and BamHI sites of the vector pET3a Trm, and then moved 
as an XbaI-BamHI fragment to the expression  vector  pST39  generating the  plasmid 
pC4181. The DYS1 and LIA1 ORFs were cloned into pET3a Trm using NdeI-HindII and 
NdeI-MluI sites, respectively, and then sequentialy transfered to  pST39  using EcoRI-
HindII and BspEI-MluI sites, respectively, to  make the  plasmid  pC4183.  Plasmid 
pC4182 contains  N-terminaly  His6-tagged HYP2 and DYS1 ORFs cloned into  pST39 
sequentialy using XbaI-BamHI and EcoRI-HindII sites, respectively.  
 To purify eIF5A, E. coli strain BL21 CodonPlus(DE3)-RIL [Agilent Tecnologies] 
or BL21(DE3)pLysS [Agilent Technologies] for toxic byproducts was transformed with 
pC4181,  pC4182,  or  pC4183,  or  mutant  derivatives and cels  were  grown in  0.5 L LB 
medium containing 100 µg/mL ampicilin at 37°C to OD600 = 0.5. Then, 0.5 mM IPTG 
was added and the culture was incubated at 25°C for 14 h or 37°C for 3-6 h for mutants. 
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Folowing  harvesting, the cel  pelet  was suspended in  40  mL Lysis  Bufer  D (50  mM 
Tris-HCl [pH 7.5], 300 mM KCl, 10 mM imidazole) and cels were broken by sonication 
using a microtip (5 cycles of 30 sec pulse folowed by 30 sec cooling at 4°C). The cel 
lysate was cleared by centrifugation at 27,000 × g for 30 min and then mixed gently with 
1  mL Ni-NTA resin [Qiagen] at  4°C for  2  h.  The resin  was transfered to a  disposable 
column [Qiagen], washed sequentialy with 10 mL Lysis Bufer D and then 10 ml Lysis 
Bufer D containing 20 mM imidazole, and then protein was eluted in 2 mL Lysis Bufer 
D containing 0.5 M imidazole. Samples were then dialyzed against Storage Bufer C (30 
mM Hepes-KOH (pH 7.5), 150 mM potassium acetate, 2 mM DTT and 10% glycerol). 
The eIF5A proteins were purified from yeast as wel. 2.5 L YPD cultures of yeast 
strains J1005 and J1119, expressing single copy C-terminal FLAG-tagged eIF5A proteins, 
were grown to OD600 3.0, washed with 1× Tris-bufered saline (TBS), and broken with 
glass beads. The lysate was cleared of unbroken cels by centrifugation at 1,900 × g for 
10  min, the extract  was clarified  by centrifugation at  27,000 × g for  30 min, and then 
mixed  with  1  mL of anti-FLAG-M2 affinity  gel (50% slury) [Sigma].  The  gel  was 
washed  with  10  mL of  1× TBS containing  0.1%  Triton  X-100, and then  bound eIF5A 
was eluted  with  200  µg/mL FLAG  peptide in  1× TBS. eIF5A  proteins  were  dialyzed 
against Storage Bufer D (30 mM Hepes-KOH [pH 7.5], 150 mM KCl, 2 mM DTT, 10% 
glycerol). 
 The  modification (unmodified,  dHyp,  or Hyp) status  of eIF5A  was assessed by 
ElectroSpray-Ionization Quadrupole-Time-of-Flight Mass Spectrometry (ESI QTOF MS, 
[Agilent Tecnologies])  by  Dr.  Peter  Backlund (Section  on  Mass  Spectrometry and 
Metabolism, NICHD). 
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2.8 Preparation of mRNA, tRNA, and ribosomes 
A  model  5’-AUGCCACCACCAAAAUAA-3’ encoding  5’-M-P-P-P-K-Stop-3’  was 
purchased [Integrated  DNA  Technologies] and  used for  preparation  of elongation 
complexes.  
 The  UGG isoacceptor  of tRNAPro was  purified from  bulk S. cerevisiae tRNA 
[Roche] using the biotinylated oligo 5’-CCAAAGCGAG AATCATACCA CTAGAC-3’ 
(BioTEG) as folows (Yokogawa et al., 2010): 400 µL streptavidin beads [Pierce] were 
washed three times with 400 µL 10 mM Tris-HCl (pH 7.5), bound to 8 nmol biotinylated 
oligonucleotide at  25°C for  30  min, and then  washed twice  with  10  mM  Tris-HCl (pH 
7.5). The beads were peleted by centrifugation for 30 sec at 1000 × g after each wash to 
remove the supernatant.  Bulk yeast tRNA [Sigma,  R5636] (180  nmol in  300 µL)  was 
mixed  with an equal  volume  of  2  M  TMA  bufer (20  mM  Tris-HCl [pH  7.5],  1.8  M 
tetramethylammonium chloride, 0.2 mM EDTA), incubated with the streptavidin beads at 
65°C for 10 min to denature the tRNA, and then the mixture was slowly cooled to 25°C 
over ~10 min to alow annealing. The beads were then washed eight times with 400 µL 
10 mM Tris-HCl (pH 7.5) to remove unbound tRNA. The tRNAProUGG was melted of the 
beads by heating to 65°C for 5 min and then eluted by centrifugation of the beads in a 
new tube pre-loaded with 2 µL 1M magnesium acetate. After repeating this melting and 
elution  process, the two eluted fractions  were combined and  precipitated  with ethanol. 
The tRNA was then resuspended in 50 µL water and quantified by measuring the OD254. 
The  purified tRNAProUGG was further treated  with nucleotidyl transferase (CCA-adding 
enzyme) to increase the proline charging eficiency. For the CCA-adding reaction, 20 µM 
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tRNAProUGG was mixed with 10 mM ATP, 10 mM cytidine-5’-triphosphate (CTP), and 6 
µM CCA-adding enzyme in 1× CCA Bufer (50 mM Tris-HCl [pH 7.5], 20 mM MgCl2, 
0.5  mM  DTT), and then incubated at  37°C for  30  min.  The  CCA-adding enzyme  was 
purified from E.coli BL21(DE3) containing pET22-CCA-His6 (from Alen Buskirk). For 
aminoacylation,  5  µM tRNAProUGG was  mixed  with  2  mM  ATP-Mg
2+,  0.3  mM  proline, 
and  100 µM  ProRS in  1× Reaction  Bufer (40  mM  Tris-HCl [pH  7.6],  10  mM 
magnesium acetate,  1  mM  DTT), and then incubated at  30°C for  30  min.  The reaction 
was  purified from  unbound  nucleotides  by  using  ProbeQuant  micro columns [GE 
Healthcare]. tRNAProUGG was extracted  by  phenol-chloroform and ethanol-precipitated. 
The S. cerevisiae His6-tagged  ProRS  was  purified as  described (SternJohn et al.,  2007) 
and  obtained from  Byung  Shin.  Yeast  Lys-tRNALys was  obtained from tRNA  Probes, 
Colege Station, TX. 
Ribosomal subunits  were  prepared from the  yeast strain YAS2488 as  described 
previously (Shin et al., 2007). YAS2488 cels were grown in a total of 10 L YPD medium 
at 30°C to OD600 = 1.0. Folowing harvesting, the cel pelet was suspended in 100 mL of 
Lysis  Bufer  E (20  mM  Hepes-KOH [pH  7.4],  100  mM potassium acetate,  2.5  mM 
magnesium acetate, 1 mg/mL heparin, 2 mM DTT, Complete protease inhibitor cocktail 
[EDTA-free, Roche], 0.4 mM AEBSF) and the cels were broken with glass beads in the 
cold room on a bead beater (5 cycles of 1 min folowed by 1 min cooling on ice). The cel 
lysate was cleared by centrifugation at 1,900 × g for 5 min folowed by 27,000 × g for 30 
min. A sucrose cushion (20 mM Hepes-KOH [pH 7.4], 100 mM potassium acetate, 2.5 
mM magnesium acetate, 0.5 M KCl, 1 M sucrose, 2 mM DTT) was prepared and layered 
with yeast ribosomal extract. Samples were subjected to ultracentrifugation in a Beckman 
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Type 70 rotor for 3 h at 165,000 × g. Folowing removal of the supernatant, the ribosome 
pelet was dissolved in 5 mL Subunit Separation Bufer (50 mM Hepes-KOH [pH 7.4], 2 
mM MgCl2,  0.5  M KCl,  2  mM  DTT) and  mixed  by rotation in the cold room for  1  h. 
Puromycin (10 µL  of  100  mM  puromycin for  1  mL sample)  was added to the sample, 
which was then incubated on ice for 15 min, folowed by 10 min at 37°C, and then 10 
min  on ice.  Samples  were then layered on a  5-20% sucrose  gradient in  50  mM  Hepes-
KOH [pH  7.4],  5  mM MgCl2,  2  mM  DTT,  0.5  M KCl.  Folowing centrifugation in a 
Beckman SW32 rotor for 6 h at 175,000 × g, samples were fractionated using a Teledyne 
ISCO Density  Gradient  Fractionator while  monitoring  OD254.  Fractions containing the 
40S and the  60S ribosomal subunits  were  pooled separately, layered  on a  1  M sucrose 
cushion and subjected to centrifugation in a Beckman Type70 rotor for 24 h at 60,000 × g. 
After decanting the supernatant, the subunit pellet was dissolved in 20 mM Hepes-KOH 
[pH  7.4],  100  mM potassium acetate,  2.5  mM magnesium acetate, and the ribosome 
concentration was determined by measuring the OD254. 
 
2.9 Preparation  of ribosome footprints and  mRNA-Seq libraries for deep 
sequencing 
Ribosome footprints were prepared as previously described (Ingolia et al., 2012; Ingolia 
et al.,  2009) with  minor  modifications (Guydosh and  Green,  2014).  Yeast strains J697 
and J699, expressing wild-type eIF5A or eIF5A-S149P mutant, respectively, were grown 
in  1 L synthetic complete (SC) media at  25°C to  OD600 =  0.5 then shifted to  non-
permissive 37°C (pre-warmed media exchange) for 2 h to inactivate expression of eIF5A 
in the  mutant strain.  Yeast cels  were  vacuum-filtered rapidly and frozen in liquid 
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nitrogen.  Frozen  pelets  were  mixed in  Lysis  Bufer  F (20  mM  Tris [pH  8.0],  140  mM 
KCl, 1.5 mM MgCl2, 1% Triton X-100, and 0.1 mg/mL CHX) then lysed using a freezer 
mil [Spex]. Lysates were clarified and treated with 15 U of RNase I [Ambion] per OD254 
unit for 1 h at room temperature while gently rotating on a mixer. Next, 80S monosomes 
were separated and fractionated  by  10-50% sucrose  density ultracentrifugation as 
described in the  polysome  profiling  method above (Section  2.2).  Colected fractions 
representing the 80S monosome peak were pooled then mRNA footprints were extracted 
by phenol-chloroform. Folowing isolation of mRNA footprint samples, footprints were 
resolved  on a  15%  7  M  urea-TBE  gel and fragments  between  25-34  nucleotides  were 
extracted and eluted. For subsequent gel extraction precipitation steps, RNA was eluted 
with 300 mM sodium acetate [pH 5.5], 1 mM EDTA, 0.1 U/µL SUPERaseIn [Ambion]. 
As  detailed by Ingolia et al. (Ingolia et al.,  2012),  RNA samples containing ribosome-
protected mRNA footprints were dephosphorylated by treatment with T4 polynucleotide 
kinase [New  England Biolabs] then ligated to a  preadenylylated linker-1 [Integrated 
DNA Technologies]: 200 U T4 RNA ligase 2 truncated [New England Biolabs], 1 µg/µL 
linker-1 in a  bufer containing  10%  PEG  50,  10%  DMSO, and  20  U  SUPERaseIn and 
heated at  37°C for  2.5  h.  Folowing linker ligation, the reverse transcription, 
circularization, rRNA subtraction and  PCR amplification steps  were  performed as 
described previously (Ingolia et al.,  2012) except rRNA subtraction  oligos  were each 
used at 3.75-7.5 µM. The oligos for yeast rRNA subtraction were: 
1b  5’-biotin-(CH2)6-GGTGCACAATCGACCGATC-3’ 
2b  5’-biotin-(CH2)6-GTTTCTTTACTTATTCAATGAAGCGG-3’ 
3b 5’-biotin-(CH2)6-TATAGATGGATACGAATAAGGCGTC-3’ 
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4  5’-biotin-(CH2)6-TTGTGGCGTCGCTGAACCATAG-3’ 
5  5’-biotin-(CH2)6-CAGGGGGCATGCCTGTTTGAGCGTCAT-3’ 
6  5’-biotin-(CH2)6-CGGTGCCCGAGTTGTAATTT-3’ 
DNA  was eluted from  TBE  gels  with  300  mM sodium chloride,  1  mM  EDTA, and  10 
mM  Tris [pH  8.0].  After  PCR amplification, cDNA libraries  were sequenced  on an 
Ilumina HiSeq2000 at the UC Riverside Sequencing facility. 
In  paralel  with the ribosome footprints,  mRNA-Seq samples  were  prepared  by 
purification of total RNA extracted from cels as described (Guydosh and Green, 2014). 
After  phenol-chloroform extraction, total  RNA  was subjected to  polyA puldown  with 
oligo-dT dynabeads [Life Technologies]. Then, the RNA was fragmented by treatment in 
a solution containing 2  mM  EDTA,  10  mM sodium carbonate, and 100  mM sodium 
bicarbonate [pH  9.2] for  20  min at  95°C. Folowing fragmentation, the  RNA  was 
precipitated and size-selected on a 15% 7 M urea-TBE gel. Unlike the ribosome footprint 
samples, 40-60 nucleotide fragments were extracted from the denaturing gel and eluted. 
Al subsequent steps for total  RNA samples  were  performed similar to the steps taken 
during ribosome footprint generation. 
Data Analysis of deep sequencing libraries was performed by Nicholas Guydosh, 
a  member  of the  Rachel  Green lab at Johns  Hopkins  Medical Institute and  Howard 
Hughes Medical Institute. 
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3.1 The significance and rationale for study 
A common  misperception is that the ribosome is a  monolithic  machine that catalyzes 
peptide  bonds at equivalent rates regardless  of the amino acid. In fact, certain residues 
including the imino acid proline are poor substrates for peptide bond formation (Pavlov et 
al., 2009; Wohlgemuth et al., 2008). At the time of my preliminary studies regarding the 
function of eIF5A in protein synthesis, it was shown that the translation elongation factor 
EF-P is essential for translation of polyproline sequences by bacterial ribosomes (Doerfel 
et al.,  2013; Ude et al.,  2013);  however, it was stil unclear  how eukaryotic ribosomes 
managed to synthesize peptide bonds with poor substrates. In this colaborative study, we 
aimed to  determine the requirements for eIF5A in  peptide  bond synthesis for  particular 
amino acids. 
In addition to the canonical elongation factors eEF1A and eEF2, eIF5A has also 
been linked to translation elongation. Depletion of eIF5A in vivo or inactivation of a ts- 
mutant  of  yeast eIF5A impaired translation elongation and stabilized  polysomes in the 
absence of CHX (Saini et al., 2009) and increased the average ribosomal transit time in 
vivo (Gregio et al., 2009; Saini et al., 2009). Moreover, addition of eIF5A resulted in a 
two-fold stimulation in the rate  of (Met-Phe-Phe) M-F-F tripeptide synthesis  using a 
reconstituted yeast in vitro translation system (Saini et al., 2009). Taken together, these 
data revealed a role for eIF5A in translation elongation as opposed to the previously held 
notion that eIF5A functioned  during translation initiation.  However, it  was  dificult to 
rationalize the essential requirement for eIF5A in  yeast  with the  modest two-fold 
stimulation  of  M-F-F tripeptide synthesis, suggesting that eIF5A  may  have a  more 
specialized and critical requirement in translation elongation. 
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 eIF5A is  of  particular interest  because it is the  only  protein that contains the 
modified amino acid  hypusine and  because eIF5A and  hypusine  have  been linked to 
tumorigenesis and cancer (Scuoppo et al.,  2012; Silvera et al.,  2010). Earlier studies 
revealed that the impact  of bacterial  EF-P on  dipeptide synthesis  varied for  diferent 
aminoacyl analogs (Ganoza and  Aoki,  2000; Glick et al.,  1979), suggesting that EF-P, 
and by extension eIF5A, may facilitate the reactivity of certain amino acids and/or tRNAs 
in  peptide  bond synthesis. Consistent  with these findings, and  during  my preliminary 
analysis  of eIF5A function in specific amino acid  or tRNA reactivity using  dual 
luciferase reporters, reports showed that  EF-P enhances the synthesis  of  proteins 
containing stretches  of consecutive  proline residues (Doerfel et al.,  2013; Ude et al., 
2013). In our folow-up analysis, we addressed whether eIF5A has a similar function in 
yeast. In our paper (Gutierez et al., 2013), we used in vivo assays in yeast and in vitro 
reconstituted translation assays to reveal a specific requirement for eIF5A in promoting 
peptide bond formation between consecutive proline residues. Addition of eIF5A relieved 
ribosomal staling  during translation  of three consecutive  proline residues in vitro 
(Gutierez et al., 2013), and loss of eIF5A function impaired translation of polyproline-
containing proteins in vivo. Thus, we proposed that eIF5A, like its bacterial ortholog EF-
P, stimulates the peptidyl transferase activity of the ribosome and facilitates the reactivity 
of poor substrates like proline. 
 
3.2 eIF5A stimulates translation through polyproline sequences in vivo 
To further  define the role  of eIF5A in translation elongation and to  determine  whether 
eIF5A, like  EF-P, stimulates translation  of specific amino acid  motifs, I  monitored the 
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expression of a set of dual luciferase reporters in isogenic yeast strains expressing wild-
type eIF5A or the ts- eIF5A-S149P mutant (Saini et al., 2009; Zuk and Jacobson, 1998). 
These dual luciferase reporters, developed by Beth Grayhack and coleagues to examine 
codon bias in translation (Letzring et al., 2010), express a single mRNA in which the 5’ 
Renila luciferase and  3’ firefly luciferase  ORFs are joined in-frame  by sequences 
encoding repeats of 10 identical codons for each of the 20 amino acids (Fig. 6A). For the 
initial analysis, the inserted sequences repeated the  optimal codon for each amino acid 
(Letzring et al.,  2010). As shown in  Fig. 6B (top panel), and as  previously  observed 
(Letzring et al., 2010), the ratio of firefly to Renila luciferase activity varied depending 
on the repeated codon. While the ratios for most constructs were similar to the no insert 
control, low ratios were observed for the ArgAGA and CysUGU reporters (Fig. 6B, top 
panel); whereas, high ratios were observed with GluGAA and PheUUC codon insertions 
(Fig.  7).  These eIF5A-independent efects  might reflect codon  or aminoacyl-tRNA 
abundance or impacts of the inserted amino acids on luciferase activity in the bifunctional 
Renila-firefly luciferase fusion protein. 
 If eIF5A stimulates the translation of specific amino acids, then the ratio of firefly 
to Renila luciferase activity is expected to decrease when these reporters are analyzed in 
the strain expressing eIF5A-S149P when grown at the semi-permissive temperature 
(33°C). As shown in Fig. 8A, the slow-growth phenotype of the eIF5A-S149P mutant at 
30°C is exacerbated at 33°C, and the mutant strain fails to grow at 37°C. The impaired 
growth at  33°C is  marked  by reduced levels  of eIF5A (Fig. 8B) and  by retention  of 
polysomes in the absence of CHX (Fig. 8C), indicative of a general translation elongation 
defect in the strain. Analysis of al 20 luciferase reporter constructs revealed that only the  
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Figure 6. eIF5A stimulates translation of polyproline motifs in vivo. 
(A)  Schematic  of Renila-firefly luciferase reporter construct.  Codon repeats  were 
inserted in-frame between the Renila and firefly luciferase ORFs (Letzring et al., 2010). 
(B) Dual luciferase reporter constructs containing 10 repeats of the indicated codon were 
introduced into isogenic  yeast strains expressing wild-type eIF5A  or ts- eIF5A-S149P. 
(Top  panel) Folowing  growth at semi-permissive  33°C, luciferase activities  were 
determined, and the firefly to Renila luciferase ratio for each construct was normalized 
to the ratio obtained from controls in which the reporter contained no insert between the 
ORFs. (Botom  panel) The fold  diference in luciferase ratios  between cels expressing 
wild-type eIF5A and eIF5A-S149P  was  quantitated and then  normalized to the  values 
obtained from the  no insert control.  *Statistical significance for  ProCCA(10)  was 
measured  by student’s t-test  with a  p-value  <0.05.  Eror  bars  were calculated as 
propagated standard erors of the mean for three independent transformants. 
(C) Dual luciferase reporters containing no insert or 10 repeats of AlaGCU or ProCCA 
were introduced into isogenic yeast strains expressing wild-type eIF5A (Left panel) or ts- 
eIF5A-S149P (Right panel). Cels were grown at semi-permissive 33°C to OD600 0.5 and 
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in the presence of 10% trichloroacetic acid (TCA), and diferent amounts of each extract 
difering by a factor of 2 were loaded in successive lanes and subjected to immunoblot 
analysis  using  polyclonal anti-firefly luciferase [Thermo  Scientific] or  polyclonal anti-
yeast eIF5A antiserum. *The  unexpected absence  of the  higher  molecular  weight 
polyubiquitinated species (polyUb) in ProCA(10) 4X lane for eIF5A-WT may be due to 
a bloting eror. 
 
Pro codon insertions demonstrated a strong dependence on eIF5A (Fig. 6B, botom panel). 
For the ProCCA reporter, the ratio of firefly to Renila luciferase in the strain expressing 
wild-type eIF5A  was  ~3.7-fold  greater than the ratio  observed in the strain expressing 
eIF5A-S149P (Fig. 6B, botom panel),  whereas this normalized ratio ranged from  0.75 
(ArgAGA) to  1.35 (GlyGGU) for reporters containing any  of the  other  19 codon 
insertions. To validate the reporter activity, western blot analysis was performed for the 
firefly luciferase protein. Whereas the Renila-firefly luciferase fusion proteins (expected 
size  of  ~99  kDa)  were largely intact for constructs containing the  AlaGCU  or  ProCCA 
codon inserts in the wild-type strain, expression of firefly luciferase was defective for the 
ProCCA,  but  not the  AlaGCU, construct in the eIF5A-S149P  mutant strain  grown at 
33°C (Fig.  6C).  These results support the reporter activity  data and suggest that 
translation  of the  3’ firefly luciferase  ORF requires the eIF5A-dependent translation  of 
the ProCCA insert. 
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Figure 7.  Summary  of the firefly to Renila luminescence ratios for each of the 
reporters transformed into wild-type eIF5A and eIF5A-S149P mutant yeast strains 
grown at 33°C.  
Ratios  of firefly to Renila luciferase activity  were  determined for three independent 
transformants of each construct, and the average ratio (x 103) and standard deviation (SD) 
are  presented.  The  values in  Figure 6 were  obtained  by  normalizing the ratios to the 
respective no insert control for each of the three sets of constructs. 
D
Amino Acid(10) eIF5A-WT (SD) eIF5A-S149P (SD)
no insert 3.09 (0.10) 6.91 (0.61)
SerUCU 3.47 (0.11) 6.85 (0.23)
HisCAC 2.34 (0.25) 5.07 (0.54)
GlnCAA 3.68 (0.22) 7.59 (0.58)
ThrACU 3.66 (0.13) 7.42 (0.05)
AsnAAC 3.97 (0.33) 7.38 (0.53)
AspGAC 3.01 (0.27) 7.17 (0.63)
GlyGGU 3.47 (0.18) 5.74 (0.23)
ProCCA 3.55 (0.15) 2.16 (0.39)
no insert 8.45 (0.27) 11.46 (0.27)
PheUUC 23.26 (0.97) 30.42 (4.11)
TrpUGG 9.46 (0.28) 10.86 (0.44)
ArgAGA 2.34 (0.35) 4.21 (0.42)
MetAUG 9.42 (0.28) 12.01 (0.58)
LysAAG 2.03 (0.50) 3.43 (0.34)
CysUGU 2.27 (0.29) 3.89 (0.57)
no insert 2.25 (0.08) 2.66 (0.12)
LeuUUG 7.22 (0.48) 8.69 (0.78)
TyrUAC 7.71 (0.81) 8.77 (1.38)
IleAUU 8.12 (1.03) 10.15 (1.35)
ValGUU 12.70 (0.82) 16.03 (2.13)
AlaGCU 2.42 (0.07) 3.00 (0.27)
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Figure 8. The ts- eIF5A-S149P mutant impairs yeast cel growth, protein expression, 
and translation elongation. 
(A) Isogenic wild-type and eIF5A-S149P mutants strains were grown to saturation, and 
4-µL volumes of serial dilutions (OD600 = 1.0, 0.1, 0.01, 0.001, and 0.0001) were spoted 
on YPD medium and incubated for 2 days at 30°C, 33°C, and 37°C. 
(B) WCEs from yeasts strains expressing wild-type eIF5A or eIF5A-S149P and grown at 
permissive (30°C) and semi-permissive (33°C) temperatures were subject to immunoblot 
analysis using antisera specific for eIF5A or eIF2B. 
(C)  Polysome  profiles  were analyzed from  wild-type and eIF5A-S149P  mutant strains 
grown  under  permissive (25°C)  or semi-permissive (33°C) conditions,  or folowing a 
temperature-shift from 25°C to 37°C for 2 h, were treated with 50 µg/mL CHX (+CHX) 
or left untreated (-CHX), and WCEs were separated on sucrose gradients and fractionated 
to  visualize  polysomes and the indicated ribosomal species.  Polysome to monosome 
(P/M) ratios were calculated by comparing the areas under the polysome and 80S peaks. 
 
To test  whether the impaired expression  of firefly luciferase from the construct 
containing the ProCCA codon repeats was specific to the mutation of eIF5A, mutants of 
two  other translation elongation factors  were evaluated.  No significant  diferences in 
firefly to Renila luciferase ratios  were  observed  when constructs containing  proline  or 
alanine codon insertions  were examined in strains expressing ts- mutants  of translation 
elongation factors eEF2 or eEF3 (Fig. 9A-B). Thus, polyproline peptide bond formation 
shows a  unique  dependence  on eIF5A.  Alternatively, this result could reflect a specific 
requirement for eIF5A to promote decoding of the ProCCA codon by tRNAProUGG. As the 
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volumes  of serial  dilutions (OD600 =  1.0,  0.1,  0.01,  0.001, and  0.0001)  were spoted  on 
YPD medium and incubated for 2 days at 30°C, 33°C, and 37°C.  
(B)  Dual luciferase reporter constructs containing  10 repeats  of  AlaGCU  or  ProCCA 
codons were introduced into the respective wild-type and eEF2 (left panel) or eEF3 (right 
panel) mutant strains, and luciferase activities were determined folowing growth at semi-
permissive 33°C. Results were quantitated as described for Figure 6B. 
(C)  Dual luciferase reporters containing  10 consecutive repeats  of the indicated  Ala  or 
Pro codons were assayed in wild-type or eIF5A-S149P mutant strains and the data was 
normalized to the no insert control as described in Fig. 6. Eror bars were calculated as 
propagated standard deviations for three independent transformants. 
 
To  define the  number  of consecutive  proline residues needed to impose a 
requirement for eIF5A, the dual luciferase reporters were modified to contain one, two, 
three, four, six, eight or ten consecutive ProCCA or PheUUC codons. As shown in Fig. 
10, luciferase ratios for the Phe codon insertion constructs were the same in the wild-type 
and eIF5A-S149P mutant strains (fold wild-type/mutant = ~1.0). Likewise, insertion of 
one  or two  proline codons  did  not significantly impact luciferase ratios in the eIF5A 
mutant strain compared to the  wild-type control. In contrast, insertion  of four  proline 
codons resulted in reduction of the luciferase ratio in the eIF5A-S149P mutant strain. (A 
modest reduction may be evident with insertion of three Pro codons as wel.) Insertion of 
six, eight or ten proline codons further exacerbated the defect, and the normalized ratio of 
firefly to Renila luciferase in the strain expressing wild-type eIF5A  was ~3-4.5–fold 
greater than the ratio  observed in cels expressing eIF5A-S149P.  These results indicate 
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that at least four (or perhaps three) consecutive proline codons are needed to impose an 
eIF5A-dependency on protein synthesis. The data also reveal a significant decrease in the 
firefly to Renila ratio between  wild-type and  mutant cels  when the  number  of 
consecutive  Pro codons is increased from  8 to  10. This unexpected lessening  of eIF5A 
dependence is  due to a  gradual increase in the firefly to Renila luciferase ratio  of the 
mutant as the number of codons is increased from 6 to 10 (data not shown). At this point, 
it is unclear how translation occurs for reporters containing longer (>6 Pro codons) Pro 
stretches when eIF5A is slightly inactivated in the S149P mutant.  
 

























































Dual luciferase reporters containing  1,  2,  3,  4,  6,  8,  or  10 consecutive  PheUUC (F) or 
ProCCA (P) codons were assayed in wild-type or eIF5A-S149P mutant strains grown at a 
semi-permissive temperature (33°C) and the fold  diference in luciferase ratios  were 
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quantitated and normalized to the no insert control as described in Fig. 6. 
 
3.3 Expression of yeast polyproline-containing proteins requires eIF5A in vivo 
Analysis of the Saccharomyces cerevisiae genome identified  549  proteins (out  of  5886 
ORFs) that contain polyproline motifs with at least three consecutive proline residues. To 
test whether expression of yeast proteins containing polyproline motifs is dependent on 
eIF5A, selected plasmids from the Yeast ORF Colection were introduced into isogenic 
strains expressing wild-type eIF5A or the ts- mutant eIF5A-S149P. Transformants were 
grown at the semi-permissive temperature  of  33°C to  partialy inactivate eIF5A-S149P 
and in galactose medium to induce the GAL1 promoter used to drive ORF expression. In 
experiments performed by Joo-Ran Kim, a member of the Dever lab, protein expression 
was monitored by Western analysis using antibodies to detect the HA-tag incorporated at 
the C-terminus of each ORF (Gelperin et al., 2005). Expression of LDB17, a regulator of 
endocytosis and containing a 9 consecutive polyproline motif, was dramaticaly reduced 
in the eIF5A  mutant strain relative to the  wild-type eIF5A strain and to the loading 
control eIF2α (no polyproline motifs) (Fig. 1A). Other yeast proteins, including EAP1 
(two 6 Pro, one 3 Pro motif), and VRP1 (multiple polyproline sequences including one 9 
Pro, one 8 Pro, one 6 Pro, four 5 Pro, three 4 Pro, and two 3 Pro motifs), also exhibited 
reduced  protein levels in the eIF5A  mutant strain (Gutierez et al.,  2013). Stable 
expression  of  TIF11 (eIF1A,  no polyproline  motifs) from a  Yeast  ORF Colection 
plasmid in the  wild-type and  mutant eIF5A strains indicates that the eIF5A-sensitive 
expression of the polyproline-containing proteins is not due to impacts on the expression 
system (e.g. the GAL1 promoter, growth at 33°C) (Fig. 11A). In addition, substituting Ala 
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subjected to immunoblot analysis  using  monoclonal anti-HA  or  polyclonal anti-yeast 
eIF2α antiserum. 
(B)  The experiment in  panel  A  was repeated  using an  LDB17 construct in  which  Ala 
codons were substituted for the nine Pro codons in the polyproline motif. 
*Experiments for Panels A and B were conducted by Joo-Ran Kim. 
 
3.4 eIF5A plays an essential role in polyproline peptide synthesis  
To confirm the requirement for eIF5A in  polyproline synthesis,  Byung  Shin, a staf 
scientist in the  Dever lab,  performed in vitro reconstituted  yeast translation assays to 
directly examine the role  of eIF5A in  polyproline  peptide  bond synthesis.  As shown in 
Figure 12A,  minimal translation initiation (48S) complexes containing  unstructured 
model  mRNAs encoding  polyproline  or  polyphenylalanine  were assembled with 
[35S]Met-tRNAi
Met in the P site of the ribosome. Folowing ribosomal subunit joining, the 
80S initiation complexes were peleted through a sucrose cushion to remove initiation 
factors and  unbound  Met-tRNAi
Met.  Next, elongation factors and the  necessary 
aminoacyl-tRNAs were added to the purified 80S complexes in the absence or presence 
of excess recombinant eIF5A. As described in more detail in Chapter 5, the recombinant 
Hyp-eIF5A  was  prepared from E. coli that co-expresses eIF5A, DYS1 and LIA1. The 
peptide synthesis activity in the assays was monitored by electrophoretic TLC (Eyler and 
Green, 2011; Youngman et al., 2004). 
The Met-Phe (M-F),  M-F-F, and  M-F-F-F  peptides resolved wel on 
electrophoretic  TLC (Gutierez et al.,  2013) and  were synthesized in the absence  or 
presence of eIF5A with less than a two-fold stimulation in the fraction of maximal yield 
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(Ymax) for formation of the peptides in the presence of eIF5A (Fig. 12B-C). These results 
are consistent with the previously reported ~2-fold stimulation of M-F-F synthesis upon 
adding eIF5A to the reconstituted system (Saini et al., 2009). In preliminary experiments, 
the proline-containing peptides Met-Pro (M-P), M-P-P and M-P-P-P were not resolved as 
discrete spots  on the  TLC (Gutierez et al.,  2013). However, incorporation  of a lysine 
residue at the  C-terminus  of the  proline  peptides enabled resolution  of the  peptides  by 
TLC and facilitated their  quantitation.  The fraction  of  maximum  peptide  yield for  Met-
Pro-Lys (M-P-K)  peptide synthesis  was increased  ~1.3-fold  by adding eIF5A (Ymax = 
0.36 in the absence of eIF5A and 0.48 in the presence of eIF5A) (Fig. 12B-C). Thus, the 
presence  of a single  Pro residue confered a  modest eIF5A  dependency for  peptide 
synthesis. In contrast, synthesis  of the  M-P-P-K  peptide containing two  prolines  was 
significantly impaired in the absence  of eIF5A (Ymax =  0.06 ±0.03); and an 8.3-fold 
stimulation of Ymax was observed upon adding eIF5A (Ymax = 0.49 ±0.02) (Fig. 12B-C). 
Similar to reports made  by  Doerfel and coleagues (Doerfel et al.,  2013), the large 
diference in reaction endpoints for the proline-containing peptides in the presence versus 
the absence of eIF5A suggests that variable and competing reactions are likely occuring 
(e.g.  peptidyl-tRNA  drop-of). Since the  observed rates reflect  both  peptide  bond 
formation and these competing reactions, the analysis was limited to the reaction 
endpoint diferences and not the observed rates. Remarkably, no detectable formation of 
the  M-P-P-P-K  peptide, containing three consecutive  proline residues, occured in the 
absence  of eIF5A  during the time course  of the experiments.  The addition  of eIF5A 
eficiently restored  M-P-P-P-K synthesis stimulating the  Ymax at least  39-fold (Ymax = 
0.58 ±0.1) (Fig. 12C). Thus, consistent with the results of the in vivo assays, eIF5A is  
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Figure 12. eIF5A stimulates synthesis of polyproline peptides. 
(A) Scheme for in vitro reconstituted translation elongation assay. 
(B) Fractions of M-F, M-F-F, M-F-F-F (left column) or M-P-K, M-P-P-K, and M-P-P-P-
K (right column) synthesis in elongation assays performed in the absence (open symbols) 
or  presence  of eIF5A (closed symbols)  were  ploted and fit to a single exponential 
equation. 
(C)  Summary  of  maximum fractions  of  peptide synthesis (Ymax, left  panel) and fold 
stimulation  of  Ymax by adding eIF5A (right  panel) calculated from the  data in  panel  B. 
Eror bars are (left panel) standard deviations from at least three independent experiments 
and (right panel) calculated propagated erors. 
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(D) Efect of eIF5A hypusine modification on peptide synthesis. Fraction of M-P-P-P-K 
synthesis in reactions lacking eIF5A, containing unmodified eIF5A (no  hypusine),  or 
containing Hyp-eIF5A  prepared from E. coli or  purified from  yeast (+5A,  yeast)  was 
ploted and fit to a single exponential equation. 
*Experiments for these assays were performed by Byung Shin. 
 
required for synthesis of peptides containing consecutive Pro residues. Moreover, these in 
vitro experiments  demonstrate that eIF5A is acting  directly to  promote  polyproline 
synthesis. 
To assess the importance  of the hypusine  modification  on eIF5A,  M-P-P-P-K 
synthesis was analyzed using diferent forms of the factor. As shown in Fig. 12D, no M-
P-P-P-K synthesis  was  detected in the absence  of eIF5A and  very litle synthesis  was 
detected in assays that included  unmodified eIF5A  prepared from E. coli. In contrast, 
hypusine-modified eIF5A,  prepared either from  yeast  or from E. coli co-expressing the 
hypusine  modification enzymes, readily stimulated  M-P-P-P-K synthesis (Ymax =  0.38 
±0.02 for  yeast eIF5A; and  Ymax =  0.45 ±0.02 for recombinant eIF5A).  Thus, the 
hypusine modification of eIF5A is necessary for eficient polyproline synthesis in vitro. 
 
3.5 Conclusion 
Our data indicate that eIF5A promotes the translation of homopolyproline sequences and 
are consistent  with recent reports  on  bacterial  EF-P (Doerfel et al.,  2013; Ude et al., 
2013). Partial inactivation  of eIF5A-S149P in  yeast, like  deletion  of the efp gene in E. 
coli (Ude et al.,  2013), impaired expression  of reporters  or native  proteins containing 
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polyproline sequences in vivo.  Moreover,  peptide synthesis assays  demonstrated that 
eIF5A (Gutierez et al., 2013) and EF-P (Doerfel et al., 2013) are critical for the in vitro 
synthesis  of  polyproline  peptides. Additionaly, in colaboration  with  Chris 
Woolstenhulme and  Alen  Buskirk at  Brigham  Young  University,  we  performed toe-
printing analyses to  monitor ribosome staling  during in vitro translation of  mRNAs 
encoding  polyproline  motifs (Gutierez et al.,  2013). In these experiments, ribosomes 
translating in the absence of eIF5A staled with diproline bound to the P-site tRNA and a 
Pro codon in the A site (presumably bound by Pro-tRNAPro). These data coroborate the 
reporter and peptide synthesis assays, and together suggest that eIF5A and, likewise, EF-














4. Genome-wide profiling reveals ribosomal staling during translation 
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4.1 The ribosome profiling strategy for the identification of translational targets 
of eIF5A 
 A large proportion of celular mRNAs are targets for protein production by the ribosome. 
To facilitate  protein synthesis, ribosomes  must locate to the appropriate start codon, 
decode the mRNA, catalyze the synthesis of peptide bonds between a peptidyl-tRNA and 
aminoacyl-tRNA, and release the completed  polypeptide chain.  However, strong 
secondary structure elements or rare codons in the mRNA, truncated coding sequences, 
low tRNA availability, or interactions between the nascent peptide and the ribosomal exit 
tunnel can  perturb the synthesis  of  peptide  bonds. To  overcome these chalenges, 
translation factors facilitate protein synthesis by maintaining translation start site fidelity, 
ensuring the  delivery  of the  proper aminoacyl-tRNA in a codon-specific  manner, and 
promoting the release  of the  polypeptide chain upon encountering a stop codon. 
Moreover, some translation factors, rather than stimulating  general  protein synthesis, 
have specialized roles in enhancing the translation  of specific  mRNAs  or the 
incorporation of specific amino acids, such as selenocysteine (Lobanov et al., 2010). 
 Polysome profile analyses indicated a general elongation defect when eIF5A was 
depleted in  yeast (Saini et al.,  2009).  Because  polysome  profile analyses  of  WCEs 
examine translation  of al  mRNAs in the cel, the  polysome retention in the absence  of 
CHX in the eIF5A  degron strain indicates that translation  of  most celular  mRNAs is 
impaired in the absence of eIF5A. However, although the polysome profile technique is 
quite  useful for identifying  general translation  defects, the technique  provides limited 
resolution and the results are  biased toward examining the  most abundant celular 
mRNAs.  
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 The ribosome  profiling strategy involves the  deep sequencing  of ribosome-
protected  mRNA fragments and is a  powerful tool to  visualize ribosome  positions 
throughout a transcriptome (Ingolia et al.,  2012).  Unlike  polysome  profile analyses, 
ribosome  profiles  provide a single  nucleotide-level snapshot  of ribosome  occupancies, 
which corelates with the relative amount of time a ribosome resides on a given mRNA 
site. In addition to  mapping ribosome  positions  within ORFs, ribosome  profiling  has 
uncovered ribosomal occupancies on large intergenic noncoding RNAs (Gutman et al., 
2013), and in the 3’ untranslated region (UTR) (Guydosh and Green, 2014) and upstream 
ORFs (Brar et al., 2012; Ingolia et al., 2009) of mRNAs. Ribosomal staling induced by a 
particular peptide (Ingolia et al., 2011), mRNA or codon sequence (Li et al., 2012), or co-
translationaly  by a  bound chaperone (Oh et al.,  2011) has also  been revealed  by 
ribosome profiling. Here, in colaboration with Nicholas Guydosh and Rachel Green of 
Johns  Hopkins  Medical Institute and  Howard  Hughes  Medical Institute and  Alen 
Buskirk and  Christopher  Woolstenhulme  of  Brighman  Young  University,  we  used 
ribosome profiling to identify the celular targets of eIF5A in yeast. Consistent with our 
studies described in the previous chapter (Gutierez et al., 2013), we identified prevalent 
ribosomal pausing along mRNA regions encoding polyproline sequences in a yeast strain 
expressing the ts- eIF5A-S149P  mutant, supporting the  notion that eIF5A functions to 
promote the translation of polyproline-containing proteins. 
 
4.2 The preparation of ribosome footprint and total mRNA libraries 
cDNA libraries  were  prepared for  deep sequencing as  described in the  Materials and 
Methods  Chapter and  by Ingolia and coleagues (Ingolia et al.,  2012) with  minor 
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modifications.  The schematic in  Fig.  13 outlines the steps for  generation  of ribosome 
footprint cDNA libraries. In  paralel  with ribosome footprints, I  prepared total  mRNA 
samples, and then randomly fragmented the RNA for total abundance measurements by 
RNA-Seq.  Normalizing ribosomal footprint sequences to total  mRNA abundance 
measurements reveals sites  of enhanced ribosome occupancy and avoids erors  due to 
altered mRNA levels or recoveries. 
 To analyze eIF5A activity,  polysome analyses  on  yeast strains expressing  wild-
type eIF5A or the ts- eIF5A-S149P mutant were performed (Saini et al., 2009; Zuk and 
Jacobson,  1998).  As shown in the  previous chapter, the eIF5A-S149P  mutant confers a 
semi-permissive  growth  phenotype at 33°C and is  non-permissive for  growth at  37°C 
(Saini et al., 2009) (Fig. 8A). In contrast to the wild-type strain, inactivation of eIF5A in 
the S149P mutant strain caused retention of polysomes in the absence of CHX. As shown 
in  Fig. 8C, a  ~4-5−fold  higher P/M ratio  was  observed in the  mutant compared to the 
wild-type strain.  This result suggests that a large  proportion  of celular  mRNAs are 
subject to translational control by eIF5A during translation elongation. Therefore, when 
ribosome  profiling the eIF5A-S149P strain,  we expected to  detect enhanced ribosome 
occupancies across many mRNAs. 
 To apply a stringent shut-of  of eIF5A function in the  mutant strain, cels  were 
grown at permissive 25°C to mid-log phase (OD600 = 0.5) and then shifted the cultures to 
37°C for two hours. To avoid possible complications associated with treating cels with 
CHX to freeze  polysomes, including an accumulation  of ribosomes at the start codon 
(Ingolia et al., 2012), cels were harvested by filtration, quickly frozen in liquid nitrogen, 
and then mixed with lysis bufer containing CHX to prevent polysome run-of during cel 
	  




Figure 13. Schematic of the ribosome footprinting protocol. 
Ribosome footprint cDNA libraries  were  prepared from  yeast extracts for  deep 
sequencing (Ingolia et al.,  2009). The runs  of  polyT represent the conversion from the 
polyA tail in the mRNA after reverse transcription. 
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lysis and extract preparation. Notably, as shown in the polysome profiles of the mutant, 
adding CHX approximately five min prior to harvesting increased the P/M ratio (Fig. 8C) 
indicating a general enhancement of mRNAs bound to elongating polysomes. Therefore, 
in  order to enrich for ribosome-protected  mRNA fragments within  ORFs and to avoid 
artifacts associated with CHX treatment, we included CHX in the lysis step after quickly 
freezing the cels (Guydosh and Green, 2014). 
 The  WCEs containing polysomes  were treated  with  RNase I as  described  by 
Ingolia and coleagues (Ingolia et al., 2012) with the expectation that unprotected tRNAs, 
rRNA and mRNA fragments would be digested, including the mRNA fragments within 
ORFs that reside  between elongating ribosomes.  After  nuclease treatment, sucrose 
density centrifugation  was  used to separate and resolve  80S  monosome fractions from 
both the  wild-type and eIF5A-S149P  mutant samples (Fig.  14). Importantly,  no 
polysomes  were  detected in either sample, indicating that the  nuclease treatment 
efectively digested the mRNA segments that were unprotected by polysomes. 
 RNA from ribosome footprint or total  RNA samples were purified folowing 
phenol-chloroform extraction  of  proteins.  The  polyadenylated  mRNA in the total  RNA 
sample  was isolated  using  oligo-dT  Dynabeads, and then the  RNA  was fragmented by 
incubation with an alkaline solution consisting of sodium carbonate, sodium bicarbonate 
and  EDTA [pH  9.2] at  95°C for  20  min (Ingolia et al.,  2009).  Both the ribosome-
protected  mRNA and fragmented total  RNA samples  were subjected to  denaturing  gel 
electrophoresis and a wide spectrum of RNA species were observed (Fig. 15). Knowing 
that the ribosome  protects an approximately  30-nucleotide  mRNA fragment (Steitz, 
1969),  RNA fragments from the ribosome footprint samples  migrating  between the 25 
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and 34 base markers were isolated for further analysis. For analysis of the total mRNA 
samples, RNA fragments between 40 and 60 nucleotides in length were selected. 
 
Figure 14. Sucrose  density  gradients for isolation  of  80S  monosomes in  nuclease-
treated lysates containing wild-type or mutant eIF5A. 
Isogenic wild-type (left panel) and eIF5A-S149P mutant (right panel) strains were grown 
under permissive (25°C) conditions then shifted to 37°C for 2 h. WCEs were treated with 
RNase I as  described, separated  on  10-50% sucrose  gradients, and fractionated to 
visualize ribosomal species.  Fractions  within the  80S  monosome  peak  were  pooled for 
preparation of protected mRNA fragment libraries. 
  
 Folowing dephosphorylation of the purified mRNA fragments, the 19-nucleotide 
universal linker-1 [Integrated DNA Technologies] (Lau et al., 2001), which is compatible 
for ligation  with  T4  RNA ligase  2 [New  England Biolabs] (Ingolia et al.,  2012),  was 
ligated to the  5’ end  of each fragment. This  polyadenylated linker  wil serve as the 
template for the subsequent reverse transcription reaction. After ligation, the  RNA 
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fragments were subjected to denaturing urea-PAGE and the properly sized products (~34-
45 bases for the ribosome-protected fragments, and  ~60-100  bases for the total  mRNA 
samples)  were excised from the  gel (Fig.  16). RNA fragments consisting  of  ~60-100 
bases were excised for the total mRNA samples to diferentiate samples from the smaler 
ribosome-protected  mRNA samples. RNA fragments consisting  of  ~60-100  bases  were 
excised for the total  mRNA samples to  diferentiate them from the smaler ribosome-
protected mRNA samples. 
 
Figure 15. Size selection of ribosome footprint and total mRNA fragments. 
Duplicate samples (from individual cultures) for isogenic strains expressing wild-type or 
mutant eIF5A were separated by denaturing urea-PAGE. For these gels and subsequent 
preparative  gels, alternating lanes were intentionaly left empty to  prevent potential 
contamination from adjacent lanes. Ribosome footprint (left  panel) and total  mRNA 
(right  panel) fragments (10  µg)  were electrophoresed together  with the  RNA ladder 
[Abnova] (from top to botom: 100, 50, 40, 30, and 20 nucleotide single-stranded RNAs), 
and  RNA  markers (from top to  botom:  60,  40,  34, and  25  bases).  Folowing 
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electrophoresis, the gel was stained with SYBR Gold [Invitrogen], and then the regions 
denoted by the red boxes were excised and prepared for RNA extraction. 
 
 
Figure 16. Linker ligation of footprint and total mRNA. 
Duplicate samples of ribosome-protected footprint (left  panel) and total  mRNA (right 
panel) fragments from isogenic strains expressing  wild-type  or  mutant eIF5A-S149P 
were separated  by  denaturing  urea-PAGE [Invitrogen].  For the footprint library (left 
panel), the unligated markers in lane 2 (from top to botom: 60, 40 and 34 bases) and the 
marker ligation in the far right lane, consisting  of  markers that  were ligated to linker-1 
(from top to botom: ~80, 60, 54 and 45 bases) are used to demarcate boxes for excision. 
For the total  mRNA library (right  panel), the  RNA ladder contains  100 and  50  base 
fragments. Folowing electrophoresis, the gel was stained with SYBR Gold [Invitrogen], 
and then the regions  denoted  by the red boxes  were excised and  prepared for  RNA 
extraction. 
  
 As  mentioned above, the atached linker-1 serves as the  primer site for reverse 
transcription  of the  RNA fragments.  The reverse transcription  primer consists  of two 
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elements:  1) sequences that are complementary to the linker, and  2) Ilumina indexing 
sequences (Ingolia et al.,  2012) that  wil enable  multiplexed sequencing.  Folowing 
reverse transcription, the resulting first-strand cDNA contains the reverse complement of 
the ribosome footprint (or fragmented RNA in total RNA prep), the universal linker, and 
the Ilumina indexing sequences. The reverse transcription products were separated and 
resolved by urea-PAGE (Fig. 17). 
 
Figure 17. Reverse transcription products of footprint and total mRNA samples. 
Duplicate samples  originating from the linker ligation step were reverse transcribed to 
create single-stranded cDNAs.  Ribosome footprint (left  panel) and total  mRNA (right 
panel) fragments  were separated and resolved  by  urea-PAGE.  The  blue arow indicates 
the  unextended  ~145-nucleotide reverse transcription  primer.  The  prominent  band  of 
~175 nucleotides within the red box in the left panel represents the reverse transcription 
primer plus the ~30-nucleotide footprint. For the total mRNA fragments (right panel), a 
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region slightly  greater than  ~175  nucleotides  was excised, consistent  with the earlier 
selection of larger fragments from total mRNA samples. 
 
 Circularization and ligation  of the single-stranded cDNA reverse transcription 
product is required to  produce a  5’ and  3’ sequence adapter flanking the ribosome 
footprint, or total mRNA, fragment (see schematic in Fig. 13). The 5’ adapter end serves 
as the site for a forward primer in preparation for the deep-sequencing library. Moreover, 
ligation of the circularized cDNA template and introduction of the 5’ adapter reduces the 
sequence-specific biases associated with RNA ligases, such as the T4 ligase used during 
the linker ligation step. Biases, like these, have been reported to distort the profiling data 
during analysis (Ingolia et al., 2009; Jayaprakash et al., 2011). 
 rRNA accounts for nearly 95% of total RNA in the cel and can severely impact 
the depth of coverage for mRNA in the profiling data. To enrich the ribosome profiling 
dataset  with ribosome-protected  mRNA footprints, rRNA contaminants  were removed 
from the footprint samples. Biotinylated oligonucleotides with complementarity to yeast 
rRNA were first incubated  with circularized  DNA samples and then  bound to 
streptavidin-coupled magnetic  beads [Life  Technologies]. This  depletion removed ~40-
60%  of the rRNA contaminants (data  not shown). Next,  PCR  was  performed  using 
barcoded and indexing primers annealed to the circularized DNA template to generate a 
deep-sequencing library (Fig. 18). 
 To assess the quality of the PCR-generated deep-sequencing library, BioAnalyzer 
profiles  were  obtained [Agilent  Technologies] (Fig.  19).  A single  peak  of  172-173 
nucleotides was evident in the analysis of the ribosome footprints generated from the 
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Figure 18. Isolation  of  PCR  products for  generation  of cDNA library for  deep 
sequencing. 
(A)  PCR  products  obtained folowing amplification  of ribosome-protected  mRNA 
fragment cDNAs  generated from strains expressing  wild-type (left  panel)  of  mutant 
eIF5A (right  panel)  were separated  on  urea-PAGE  gels and stained  with  SYBR  Gold 
[Invitrogen]. The red boxes indicate the regions containing ~175 nucleotide cDNAs that 
were excised and  purified.  The faster  migrating fragment  below the red  box represents 
the unextended reverse transcription primer. 
(B)  The cDNA  products from the total  mRNA samples  of strains expressing  wild-type 
(left panel) or mutant eIF5A (right panel) were amplified by PCR and separated by urea-
PAGE. The cDNA species that were excised and eluted are enclosed by a red box. 
  
strains expressing wild-type or mutant eIF5A. The total mRNA deep-sequencing libraries 
included slightly larger RNA segments for both wild-type and mutant eIF5A of 176-186 
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nucleotides (data  not shown).  Altogether, al samples  were  of  high-quality and  were 
subjected to multiplexed Ilumina deep sequencing on a HiSeq2000 at the UC Riverside 
Sequencing facility. 
 
Figure 19. BioAnalyzer profiles of cDNA deep-sequencing libraries. 
The cDNAs isolated as shown in  Figure  18 were  prepared for  Agilent  BioAnalyzer 
analysis  on a  high-sensitivity DNA chip according to the  manufacturer’s  procedure 
(Agilent Technologies,  2013). BioAnalyzer  profiles for cDNAs  obtained from  RNA 
footprints of wild-type eIF5A (top panel) or eIF5A-S149P samples (botom panel) were 
generated. Arbitrary fluorescence unit [FU] measurements are ploted on the y-axis, and 
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the  x-axis  displays the size  of the  DNA fragments; the  mobility  of the short (35 
nucleotides) and long (10,380 nucleotides) standards are indicated. 
 
4.3 Ribosome  profiling reveals  widespread ribosomal pausing  and  drop-of 
around polyproline motifs 
In colaboration with Nicholas Guydosh, Alen Buskirk, Christopher Woolstenhulme, and 
Rachel  Green at Johns  Hopkins  Medical Institute,  we  proceeded to align the  deep-
sequencing results  with the  yeast transcriptome. If  mutation  of eIF5A causes ribosomal 
pausing,  we  hypothesized that  distinct ribosome footprints  would  be  more  prevalent in 
the eIF5A-S149P mutant than in the wild-type strain. Due to length and content biases in 
the ribosome-protected  mRNA sequences during the library  preparation, and  depth  of 
coverage limitations, that  made  more sequences  more enriched than  others, we 
encountered  dificulties in analyzing the isogenic  wild-type strain (J697).  These issues 
did  not severely impact the  generation  of samples for the  mutant strain (J699) as a 
significant number of mapped reads were between ~27-30 nucleotides (data not shown). 
Therefore, for comparative analysis, we used ribosome footprint data from the wild-type 
strain  BY4741 that  was  obtained  previously by  Nicholas  Guydosh. This is a  possible 
shortcoming  of the analysis as  we  would  have  prefered to  use footprint  data from an 
isogenic  wild-type strain. The  most  prominent  diference  when comparing the recovery 
of ribosome-protected  RNA fragments in the  wild-type (BY4741) versus the eIF5A 
mutant strain was the enriched recovery of ribosomes on sequences encoding polyproline 
in the mutant strain. 
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 Using algorithms he  developed, Nicholas  Guydosh analyzed the  distribution  of 
ribosome-protected mRNA fragments. Interestingly, whereas the strain expressing wild-
type eIF5A (BY4741) exhibited a  uniform translational eficiency (ribosome  density 
before and after  polyproline segments  =  ~1.0), the strain expressing the eIF5A-S149P 
mutant showed a step-wise decrease in ribosome density folowing polyproline sequences 
as the number of consecutive proline residues increased (Fig. 20A). Thus, the ability of 
ribosomes to translate  polyproline stretches in the absence  of eIF5A  becomes  more 
troublesome as the number of consecutive proline residues increases. Meta-analysis of al 
genes encoding six consecutive proline residues (in S. cerevisiae, this includes 21 genes) 
revealed a  pronounced accumulation  of ribosome  occupancies  within the  polyproline 
stretch in the mutant strain, whereas the wild-type strain revealed a uniform distribution 
of averaged ribosome densities along the same colection of mRNA transcripts (Fig. 20B). 
Moreover, an mRNA encoding the yeast TIM50 protein, a component of the translocase 
of the inner  mitochondrial  membrane complex, showed  nearly equivalent ribosome 
occupancies throughout the mRNA transcript in the wild-type strain BY4741. However, 
while ribosome densities were largely similar across the 5’ end of the ORF in the mutant 
strain, a sudden  drop-of  of ribosome  occupancies  was clear folowing a seven 
consecutive  polyproline  motif (Fig.  20C).  These signatures  of ribosomal  pausing (Fig. 
20B)  or  drop-of (Fig.  20C) at  polyproline sequences in the eIF5A  mutant strain 
coroborate  our  published results (Gutierez et al.,  2013) and  demonstrate that eIF5A 
plays a crucial role in promoting the translation of polyproline sequences for a significant 
number of mRNAs in the yeast genome.  
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Figure 20. Genome-wide ribosome pausing and drop-of at polyproline sequences in 
the eIF5A mutant strain. 
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(A) Translational eficiency becomes rate-limiting as polyproline length increases in the 
eIF5A-S149P  mutant. To calculate translational eficiency, sequencing reads from the 
ribosome-protected  mRNA samples are  normalized to the total  mRNA samples. Using 
these  normalized ratios, translational eficiency  was  determined  by comparing the 
ribosome  occupancies after a  polyproline  motif  with the  occupancies  before the  motif. 
BY4741 is a  wild-type strain  derived from the same  S288C  background as the eIF5A 
mutant. 
(B) Ribosome occupancies, as mapped footprints in aggregate from wild-type (left panel) 
and eIF5A-S149P (right panel) strains, were analyzed at -150 to +150 nucleotides relative 
to the first nucleotide of the first proline codon, of a run of six consecutive prolines, set at 
0.  Reads are  ploted as reads  per  milion (rpm)  mapped reads after Ilumina  deep 
sequencing. 
(C) Ribosome occupancies along the entire 1430-nucleotide TIM50 mRNA transcript for 
wild-type (black) and eIF5A-S149P mutant (red) strains.  
*Data analyses in this figure were conducted by Nicholas Guydosh. 
 
4.4 Conclusion 
In this chapter, I present ribosome profiling results that support a genome-wide role for 
eIF5A in  polyproline synthesis.  Using a set  of  molecular biology techniques, ribosome 
footprint  deep-sequencing libraries for  both  wild-type and  mutant eIF5A-S149P strains 
were  prepared.  The sequence reads  were then  mapped to the  yeast transcriptome to 
identify sites of high and low ribosome occupancy. Analysis of the mutant strain revealed 
prevalent ribosome pausing at polyproline sequences and loss of ribosome densities after 
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the  polyproline  motif in the TIM50 mRNA. In addition, an increase in the  polyproline 
length inversely corelated  with the ability  of ribosomes to translate through the 
polyproline segment.  Altogether, this  data supports the initial results  using in vivo 
reporter and in vitro peptide synthesis assays that was presented in the previous chapter, 
and  demonstrates that eIF5A  plays a  genome-wide role in  promoting translation  of 
polyproline  motifs. Future ribosome  profiling  work  wil focus  on repeating these 
experiments. It  wil  be critical to concurently analyze isogenic  wild-type and eIF5A 
mutant strains. In addition, by analyzing more extensive libraries of ribosome-protected 
mRNA fragments, it may be possible to identify other peptide motifs that require eIF5A 
for their synthesis. 
  
	  










5. Identification and characterization of eIF5A mutants that require 
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5.1 The significance and rationale for study 
The  hypusine  modification  on eIF5A is essential for celular  protein synthesis and cel 
growth,  but its requirements for eIF5A function remains  poorly  understood.  Hypusine, 
which is  named for its  hydroxyputrescine and lysine  moieties (Shiba et al.,  1971), is 
highly conserved in al eukaryotic eIF5A and some archaeal aIF5A proteins (Bartig et al., 
1992; Bartig et al., 1990; Gordon et al., 1987a; Park et al., 1997). Interestingly, eIF5A is 
the only celular protein known to contain hypusine (Park et al., 1981). Increasing levels 
of hypusine formation  have  been  directly corelated  with increased rates  of  protein 
synthesis in mammalian cels (Cooper et al., 1982; Cooper et al., 1983), and Hyp-eIF5A 
stimulated  polyproline synthesis in in vitro reconstituted  yeast translation assays 
(Gutierez et al.,  2013) (Fig.  12D).  Hypusination  on eIF5A  occurs in two steps that 
require the enzymes DHS and DOHH. In the first step, DHS transfers an N-butylamine 
group from the  polyamine spermidine to the ε-amino  group  of a specific lysine residue 
(K51 in  yeast;  K50 in  humans) in eIF5A to form  deoxyhypusine.  Then,  DOHH adds a 
hydroxyl group to deoxyhypusine to form hypusine on eIF5A. The hypusine modification 
is essential for eIF5A function as substitution of the conserved lysine residue by arginine 
blocks hypusination and abolishes the ability of yeast or human eIF5A to substitute for 
wild-type eIF5A in yeast (Magdolen et al., 1994; Schnier et al., 1991). 
 In this study,  we aimed to  probe the functional requirements  of the  hydroxyl 
group on hypusine. The LIA1 gene encoding yeast DOHH is non-essential in budding and 
fission yeast (Park et al., 2006; Weir and Yafe, 2004); whereas loss of DOHH was found 
to cause a recessive lethal phenotype in C. elegans (Sievert et al., 2014; Sugimoto, 2004), 
Drosophila (Patel et al.,  2009), and  mouse (Sievert et al.,  2014). Here, I identified a 
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group of eIF5A mutants that require LIA1 function for yeast growth. Al of the mutations 
are located in the  N-terminal  domain  of eIF5A and impair translation in vivo in the 
presence  or absence  of LIA1.  Whereas it  was  previously  postulated that  hydroxylation 
was required to stabilize the  hypusine modification and  prevent the  back conversion  of 
deoxyhypusine to  unmodified eIF5A, MS analyses  of  wild-type and  mutant forms  of 
eIF5A indicated that loss of LIA1 did not lead to accumulation of unmodified forms of 
eIF5A. In contrast, in vivo reporter and in vitro reconstituted  yeast translation assays 
revealed a requirement for the hydroxyl group for the eIF5A mutant proteins to stimulate 
Met-Pro-Pro-Pro-Lys (M-P-P-P-K) peptide synthesis.  Taken together, these results 
provide evidence for a critical role  of the  hydroxyl  group  on  hypusine in  peptide  bond 
formation. We propose that the hydroxyl group facilitates the positioning of the hypusine 
moiety within the PTC of the ribosome.  
 
5.2 Isolation of randomly mutated HYP2 alleles that confer a strong slow-growth 
phenotype in the absence of LIA1 
In Saccharomyces cerevisiae, strains lacking the chromosomal LIA1 gene  have slight 
slow-growth phenotypes compared to wild-type yeast on rich medium (Park et al., 2006; 
Park, 2006). To understand the non-essential role of LIA1 in yeast, we screened for HYP2 
(encoding eIF5A in  yeast) mutants that require LIA1 function.  More specificaly, I 
performed a genetic screen for mutations in HYP2 that confer a normal or slow-growth 
phenotype on their own but cause exacerbated growth phenotypes when LIA1 is repressed. 
To perform the screen, I combined galactose-inducible expression of LIA1 with a plasmid 
shufling strategy in strain J1058 (MATa trp1-Δ63 ura3-52 leu2-3 leu2-112 GAL2+ gcn2Δ 
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hyp2:HPHMX anb1:NAT GAL-LIA1:KANMX4 p[HYP2,  URA3]) to identify  mutant 
aleles in HYP2 that are sensitive to loss  of LIA1 (Fig.  21A-B). In total,  979  yeast 
transformants containing a HYP2 mutant  plasmid were screened for  growth  on  both 
galactose-containing  medium,  where LIA1 expression is  maintained, and  on  glucose-
containing  medium,  where LIA1 expression is repressed.  Three LIA1-dependent 
transformants exhibited synthetic growth  defects when LIA1 expression  was repressed, 
indicating that these strains contain  mutations in HYP2 that require LIA1 function (Fig. 
21C).  The  plasmids containing the eIF5A  mutations  were  purified from individual 
transformants, re-tested to confirm the phenotype, and then sequenced. The three eIF5A 
mutants included one alele with a double mutation (eIF5A-C23Y,V60D) and two aleles 
with single mutations (eIF5A-N79I and eIF5A-S74F). Additionaly, in a candidate-based 
mutational analysis  of residues  within the  highly conserved  hypusine loop, the eIF5A-
H52A mutant was also found to exhibit a synthetic growth defect when LIA1 expression 
was repressed in yeast.  
Because GAL-LIA1 expression is  not completely repressed  under  glucose 
conditions, the  plasmids expressing the eIF5A  mutants  were introduced into isogenic 
LIA1+ (J1005) or lia1Δ (J1119) strains by plasmid shufling, and the growth of individual 
colonies  was assessed  by streaking transformants  on  minimal  medium containing al 
amino acids except leucine (Synthetic  Complete - leucine,  SC-Leu;  note, the eIF5A 
mutant plasmids contain a LEU2 marker) (Fig. 21D). Intriguingly, the strains harboring 
plasmids that express eIF5A-N79I and eIF5A-C23Y,V60D exhibited synthetic lethal 
phenotypes  when LIA1 was  deleted, while the strains expressing eIF5A-H52A and 
eIF5A-S74F displayed synthetic growth defects when LIA1 was deleted. When the two 
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Figure 21. Genetic screen to identify LIA1-dependent mutants of eIF5A in yeast. 
(A) Schematic of yeast genetic screen using strain J1058. Galactose-inducible expression 
of LIA1 is combined with a plasmid shufling strategy on plates containing 5-fluoroorotic 
acid (5-FOA) to swap the wild-type [HYP2, URA3] plasmid for a mutant [hyp2
*
, LEU2] 
construct.  The library  of [hyp2
*
, LEU2]  mutant  plasmids  was  generated  by eror-prone 
PCR  using a low-fidelity  DNA  polymerase.  Yeast transformants  were screened for 
normal or slow-growth on galactose medium where LIA1 is expressed and for slower or 
no growth on glucose medium where LIA1 expression is repressed. 
(B)  RT-PCR analysis  of LIA1 expression in strain J1058.  Total RNA  was  prepared for 
cels  grown in  galactose (lane  1)  or  glucose (lane  3)  medium, and  RT-PCR  was 
performed using primers designed to amplify a ~975 bp product for LIA1. 
(C)  Transformants  were isolated,  grown to saturation in  Yeast  Peptone  Galactose 
(YPGAL)  medium, and  4-µl  volumes  of serial  dilutions (OD600 =  1.0,  0.1,  0.01,  0.001, 
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(D) Empty  vector  or LEU2 plasmids expressing  wild-type  or the indicated  mutant 
versions of eIF5A were introduced into isogenic LIA1+ (J1005) or lia1Δ (J1119) strains. 
The resulting strains, carying two eIF5A  plasmids,  were replica-plated to  5-FOA 
medium to select for cels that  have lost the URA3 plasmid containing the  wild-type 
eIF5A alele. Finaly, the strains containing only the eIF5A, LEU2 plasmid were streaked 
on SC-Leu medium and incubated for 3 days at 30°C. 
(E)  The strains from  Figure  21D containing the eIF5A  mutant  plasmids  were  grown to 
saturation in SC (-Leu) medium, and 4-µl volumes of serial dilutions (OD600 = 1.0, 0.1, 
0.01, 0.001, and 0.0001) were spoted on SC (-Leu) medium and incubated for 3 days at 
30°C or 37°C. 
 
mutations in the eIF5A-C23Y,V60D  double  mutant  were separated and tested 
independently, the eIF5A-C23Y and eIF5A-V60D single  mutants exhibited  wild-type 
growth  phenotypes in the absence  or  presence  of LIA1.  Thus, the synthetic lethal 
phenotype is dependent on the simultaneous mutation of Cys23 and Val60 together with 
the loss of the hydroxyl group on hypusine. In an LIA1+ background, al mutants, except 
the strain expressing eIF5A-S74F,  have  mild ts- phenotypes  when  grown at  37°C (Fig 
21E). In contrast, al of the LIA1-dependent mutants had lethal or severe ts- phenotypes at 
37°C in the lia1Δ background. Notably, the strains expressing eIF5A-H52A and eIF5A-
C23Y,V60D are constitutively slow-growth in a  wild-type (LIA1+)  background, 
indicating that these mutations impair the function of the Hyp form of eIF5A. Overal, the 
screening strategy identified eIF5A mutations that impose an LIA1 requirement for eIF5A 
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function in  yeast, suggesting that the  hydroxyl  group  on  hypusine serves a critical 
function for eIF5A. 
 
5.3 LIA1-dependent mutations in HYP2 are positioned in the N-terminal domain 
of eIF5A 
Similar to bacterial EF-P, eIF5A was predicted to bind between the P and E sites of the 
80S ribosome and adjacent to the P-site tRNA (Blaha et al., 2009; Gutierez et al., 2013). 
In  directed  hydroxyl radical  probing experiments, the  hypusine loop  was found to  be 
positioned near the CCA acceptor end of the P-site tRNA. However, unlike eIF5A, EF-P 
has a third  C-terminal  domain that  overlaps the  30S subunit.  Thus, it is thought that 
eIF5A  primarily interacts  with the  60S subunit. Incidentaly, the residues  20-90  of the 
eIF5A  N-terminal  domain represent the required region for  binding  DOHH and for 
efective  hydroxylation  of the  deoxyhypusine-containing substrate (Kang et al.,  2007). 
The LIA1-dependent eIF5A mutants identified in the screen are located in the N-terminal 
domain of eIF5A (Fig. 22). Specificaly, residues C23 and V60, identified in the eIF5A-
C23Y,V60D double mutant, are located on the β1 and β4 strands respectively. Residues 
S74 and  N79 are  positioned  on the β5 and β6 strands, respectively, and  H52, a residue 
present in eukaryotic eIF5A and archaeal aIF5A but absent in bacterial EF-P, is adjacent 
to  K51, the site  of  hypusine  modification. Examination of the approximate  positions of 
these residues on the EF-P–70S ribosome co-complex (Blaha et al.,  2009), al residues 
except C23 are surface-exposed and interact with the ribosome (V60, S74, N79) or the P-
site tRNA (H52).  Notably, I did  not identify any  mutations that exhibited an LIA1 
requirement in the  C-terminal  domain of eIF5A;  however, the screen  was clearly  not 
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(Botom)  Ribbons representation  of Saccharomyces cerevisiae eIF5A (PDB:  3ER0) 
generated using PyMOL software (PyMOL Molecular Graphics System, Version 1.5.0.4 
Schrödinger, LLC). The eIF5A N-terminal domain is colored in green and the C-terminal 
domain is shown in  blue.  The sites  of LIA1-dependent  mutations are depicted as sticks 
and highlighted: C23,V60 (cyan), H52 (red), S74 (yelow), and N79 (orange). Hypusine 
at position 51 is modeled on the structure and depicted in stick mode. 
 
5.4 LIA1-dependent eIF5A mutants exhibit altered polysome profiles 
In  previous studies,  polysome  profile analyses and eIF5A  depletion experiments  were 
combined to assess eIF5A function. While one report observed a loss of larger polysomes 
and an accumulation  of  80S  monosomes, indicating a translation initiation  defect 
(Henderson and Hershey, 2011), other reports revealed polysome retention in the absence 
of CHX upon depletion of eIF5A (Saini et al., 2009) or when shifting eIF5A ts- mutants 
to a restrictive temperature (Zaneli et al., 2006), revealing a role in translation elongation. 
To assess the impact of the LIA1-dependent eIF5A mutants on general protein synthesis, I 
performed  polysome  profile analyses  of yeast strains expressing eIF5A-H52A, eIF5A-
S74F, eIF5A-N79I, or eIF5A-C23Y,V60D in an LIA1+ background and eIF5A-H52A, or 
eIF5A-S74F in an lia1Δ background  with the expectation that loss  of LIA1 would 
exacerbate the translation defects associated with the mutations. 
In order to freeze translating ribosomes in growing yeast cultures, the eukaryotic 
translation elongation inhibitor CHX was added just prior to harvesting. CHX is thought 
to inhibit the translocation  of the  mRNA and tRNA  on elongating ribosomes  by 
occupying the  E site (Schneider-Poetsch et al.,  2010).  To  determine  whether any LIA1-
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dependent eIF5A mutations confered translation elongation defects, yeast cultures were 
also  harvested in the absence  of the CHX treatment. If any mutant strains exhibited 
polysome retention similar to  wild-type strains in the  presence  of CHX, then those 
mutants  were  determined to  have  defects in translation elongation.  Consistent  with the 
fact that removal of LIA1 did not result in any severe growth defects (Fig. 21D-E), loss of 
LIA1 resulted in  polysome run-of in the absence  of  CHX and an accumulation  of  80S 
monosomes similar to  wild-type strains (Fig.  23A).  On the  other  hand, the strain 
expressing eIF5A-H52A exhibited  polysome retention in the absence  of CHX (P/M  = 
0.80 versus 0.18 for the wild-type control), indicative of a defect in translation elongation 
(Fig. 23B). However, loss of LIA1 in the strain expressing eIF5A-H52A did not further 
increase the  P/M ratio (P/M  =  0.71), suggesting that the synthetic  growth  defect is  not 
due to a more pronounced elongation defect. We are uncertain why loss of LIA1 in the 
strain expressing eIF5A-H52A does not result in a more deleterious translation defect in 
polysome profiles. It may be that loss of LIA1 severely impairs translation of a subset of 
mRNAs encoding  proteins that are critical for cel  growth and this severely impaired 
translation cannot  be  detected  over the  general  background translational inhibition 
observed in the  polysome  profiles.  Alternatively, it  may  be  possible that translational 
staling in the lia1Δ strain expressing eIF5A-H52A could subject this subclass of mRNAs 
to quality control mechanisms leading to their degradation.  
While the polysome profile of the strain expressing eIF5A-S74F (P/M (-CHX) = 
0.24; P/M (+CHX) = 2.16) was similar to the wild-type control, combining loss of LIA1 
with the eIF5A-S74F mutation resulted in a severe loss of polysomes in the presence of 
CHX (P/M = 0.52) (Fig. 23C). Similarly, the strain expressing eIF5A-N79I, though 
	  
	   102 
 
 
Figure 23. LIA1-dependent eIF5A  mutants exhibit translation elongation  defects 
and a loss of polysomes. 
Polysome  profiles  were analyzed from  wild-type and  mutant strains  grown at  30°C to 
mid-log phase, treated with 50 µg/ml CHX (+CHX) or left untreated (-CHX), and WCEs 
were separated  on sucrose  gradients and fractionated while  monitoring absorbance at 
OD254 to  visualize  polysomes and the indicated ribosomal species. P/M ratios  were 
calculated by comparing the areas under the polysome and 80S peaks.  
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showing a  minor slow-growth  defect in an LIA1+ background (Fig.  21C-D), exhibited 
loss of polysomes in the presence of CHX (Fig. 23D). Traditionaly, it is thought that the 
absence  of  polysomes in the  presence  of  CHX is indicative  of a translation initiation 
defect (Foiani et al.,  1991; Hartwel and  McLaughlin,  1969). While it is  possible that 
some  of the eIF5A  mutations are  directly impairing translation initiation, an alternative 
explanation for the apparent initiation  defect is that severe impairment  of translation 
elongation in the  mutants is triggering surveilance  pathways and subsequent  mRNA 
turnover and loss of polysomes. The eIF5A-C23Y,V60D double mutant did not show any 
significant defects in translation in the LIA1+ background (Fig. 23E), and it is not known 
if the synthetic lethal phenotype for this mutant in the lia1Δ background (Fig. 21D-E) is 
due to a severe translation defect. As the polysome analyses did not provide clear insights 
into the LIA1-dependence of the eIF5A mutations, it is possible that the residues mutated 
in the eIF5A  mutants and the  hydroxyl  group  on hypusine serve  distinct functions to 
maintain cel  viability.  We  hypothesized that loss  of the  hydroxyl  group  on  hypusine 
could impair the function of the eIF5A mutants in three possible ways: 1) decrease eIF5A 
protein levels,  2) impair stability  of the  hypusine  modification,  or  3) impair eIF5A 
function to promote translation elongation. 
 
5.5 Loss of LIA1 does not result in decreased levels of the eIF5A mutant proteins  
The first hypothesis to consider was that the synthetic growth defects in the hyp2 lia1Δ 
double  mutants were  due to lower eIF5A  protein levels.  To test this  hypothesis, 
immunoblot analyses  were  used to  monitor the levels  of  C-terminaly  FLAG-tagged 
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possible  degradation  of  proteins in the extracts  by celular  proteases. WCEs  were 
separated  by  SDS-PAGE and subjected to immunoblot analysis  using anti-FLAG  or 
polyclonal anti-yeast eIF2α antiserum. 
 
5.6 LIA1-dependent eIF5A  mutations  do  not  promote the reversibility  of the 
deoxyhypusine modification 
In  previous reports, the  DHS-catalyzed formation  of  deoxyhypusine was found to  be 
reversible (Park et al., 2003). Assays containing [3H]dHyp-eIF5A, human deoxyhypusine 
synthase,  NAD, and  1,3-diaminopropane,  generated [3H]spermidine, a  precursor for 
deoxyhypusine  biosynthesis. Intriguingly,  when [3H]Hyp-eIF5A replaced [3H]dHyp-
eIF5A in this assay,  no reversal to [3H]spermidine  was  observed. Moreover,  Park et. al 
determined that the DHS forward reaction was largely favorable compared to the reverse 
reaction in formation of a DHS-imine intermediate (Park et al., 2003). Thus, by forming a 
stable  product such as  Hyp-eIF5A,  hydroxylation could function to  deplete the  dHyp 
intermediate and drive the equilibrium of the DHS reaction forward. 
 In an efort to test  whether the LIA1-dependent eIF5A  mutations  promote the 
reverse DHS reaction and result in the accumulation of unmodified forms of eIF5A, we 
performed ESI  QTOF MS analysis in colaboration  with  Peter  Backlund to assess the 
modification status  of intact LIA1-dependent eIF5A  mutant  proteins expressed in  yeast. 
We analyzed intact eIF5A protein to avoid biases associated with protease digestion used 
to generate peptide fragments. If loss of LIA1 combined with specific mutations in eIF5A 
resulted in the loss of dHyp-eIF5A and the accumulation of unmodified forms of eIF5A, 
	  
	   106 
then hydroxylation could function to stabilize the modification and the synthetic growth 
defects could be atributed to the loss of the functional deoxyhypusine form of eIF5A. 
 MS analyses were performed on intact C-terminal FLAG-tagged eIF5A proteins 
purified from LIA1+ or lia1Δ  yeast strains.  Whereas  MS analysis  of intact  wild-type 
eIF5A purified from the LIA1+ strain confirmed the presence of hypusine on eIF5A (MW 
= 18187 Da), eIF5A purified from the lia1Δ strain accumulated in the dHyp form (MW = 
18171 Da) (Fig. 25A). Importantly, in this analysis, no unmodified eIF5A (MW = 18100 
Da)  was observed. It is  noteworthy that eIF5A expressed in  yeast is  diferentialy 
phosphorylated on Ser2. While this phosphorylation does not appear to be important for 
eIF5A function (Kang et al.,  1993; Klier et al.,  1993),  both the  phosphorylated and 
unphosphorylated (80 Da less) forms of eIF5A were detected in these experiments (Fig. 
25A) and the phosphorylation of eIF5A did not appear to be influenced by the presence 
or absence  of LIA1.  MS analysis  of  purified eIF5A-H52A revealed two  major  peaks 
consisting of Hyp (MW = 18121 Da) and dHyp forms of eIF5A-H52A (MW = 18105 Da) 
in the LIA1+ yeast background (Fig. 25B). The presence of both Hyp- and dHyp-eIF5A-
H52A in LIA1+ strains is consistent  with the  notion that residues in the  hypusine loop 
contribute to LIA1 (DOHH) recognition of dHyp-eIF5A (Cano et al., 2008; Kang et al., 
2007). Furthermore, it is noteworthy that overexpression of LIA1 partialy suppressed the 
constitutive slow-growth  phenotype  of the eIF5A-H52A  mutant strain, suggesting that 
eIF5A-H52A is  poorly recognized  by the DOHH enzyme (Fig.  25C).  These results are 
consistent  with the results from  previous studies  of  human eIF5A expressed in  yeast 
where mutation of His51, adjacent to the Lys50 site of hypusine modification in human 
eIF5A, impaired hydroxylation of deoxyhypusine (Cano et al., 2008). Analysis of eIF5A- 
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H52A purified from the lia1Δ strain revealed the predominantly dHyp form of the protein 
with no accumulation of unmodified eIF5A-H52A (MW = 18034 Da) (Fig. 25B). Finaly, 
we also examined the eIF5A-S74F mutant. Like wild-type eIF5A, purified eIF5A-S74F 
was mostly Hyp (MW = 18247 Da) when purified from LIA1+ strain and dHyp (MW = 
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of LIA1 and thus, the absence  of the  hydroxyl  group  on  hypusine,  does not  drive the 
reversibility  of the  DHS reaction for the eIF5A-H52A and eIF5A-S74F mutants as an 
accumulation  of  unmodified eIF5A  was  not  observed in  yeast.  These findings are 
inconsistent  with the  previously  held  notion that  hydroxylation  of  deoxyhypusine 
prevents the back reaction of deoxyhypusine to unmodified eIF5A. While we cannot rule 
out the  possibility that the reversible  back reaction  may  be specific to eIF5A in  higher 
eukaryotes (Sievert et al.,  2014), the results  of the  MS analyses indicate that 
hydroxylation is  not required for stable  modification  of eIF5A in  yeast, and instead 
suggest that the primary requirement for hydroxylation of deoxyhypusine on the eIF5A 
mutants is to promote eIF5A function during protein synthesis. 
 
5.7 Impaired stimulation  of  polyproline synthesis  by  deoxyhypusine forms  of 
eIF5A mutants 
Based  on  biochemical and  genetic studies, eIF5A and its  bacterial  homolog  EF-P are 
factors that  promote translation of mRNAs encoding consecutive  proline residues 
(Doerfel et al., 2013; Gutierez et al., 2013; Ude et al., 2013). As stimulation of M-P-P-P-
K peptide synthesis  by eIF5A  depends on the  hypusine  modification (Gutierez et al., 
2013) (Fig.  12D),  we rationalized that the  hydroxyl  group  on  hypusine  may facilitate 
eIF5A function as wel. To determine the functional requirements of the hydroxyl group 
on eIF5A for stimulation of polyproline synthesis, I utilized the in vivo and in vitro assays 
previously  described (Gutierez et al.,  2013).  First,  using the  dual luciferase assays 
described in Chapter 3 and by Letzring et al. (Letzring et al., 2010), I measured the ratio 
of firefly to Renila luciferase activity for reporters containing  no insert and  10 codon 
	  
	   110 
repeats for  AlaGCU  or  ProCCA in strains containing (J1005)  or lacking (J1119) LIA1 
(Fig  26A).  No  major  diferences in firefly to Renila luciferase ratios  were  observed 
between wild-type and mutant strains for the AlaGCU or the ProCCA reporters. Similarly, 
the LIA1+ strains expressing eIF5A-H52A  or eIF5A-S74F exhibited  no significant 
changes in reporter activity for constructs containing the same  AlaGCU  or  ProCCA 
repeats (Fig  26B, left  panel).  Conversely, the firefly to Renila ratio for the  ProCCA 
reporter was significantly reduced in the lia1Δ strain expressing eIF5A-H52A or eIF5A-
S74F (~45% for H52A versus WT; ~30% for S74F versus WT). These results reveal that, 
like the ts- eIF5A-S149P mutant (Fig. 6B), the deoxyhypusine forms of eIF5A-H52A and 
eIF5A-S74F are impaired for polyproline synthesis in vivo. 
 As described above, eIF5A strongly stimulated the synthesis of M-P-P-K and M-
P-P-P-K in in vitro reconstituted  yeast translation assays (Gutierez et al.,  2013) (Fig. 
12B-C). Using similar in vitro assays (see schematic in Fig. 12A), I examined M-P-P-P-K 
peptide synthesis using reconstituted yeast translation assays and purified Hyp or dHyp 
forms  of eIF5A, eIF5A-H52A,  or eIF5A-S74F from  yeast (the  modification  of these 
proteins was assessed by MS in Fig. 25). I reasoned that if the deoxyhypusine forms of 
the eIF5A mutants are defective relative to the Hyp forms of these factors in M-P-P-P-K 
synthesis, then the  hydroxyl  group  on  hypusine is contributing to eIF5A function.  As 
previously  described, I limited the analysis to  overal  yield (Ymax values) and reaction 
endpoints as  opposed to  observed rates (Gutierez et al.,  2013) (see Chapter  3). 
Consistent with previous results (Fig. 12D), Hyp-eIF5A strongly stimulated M-P-P-P-K 
peptide synthesis (Ymax =  0.06 ±0.01 in the absence  of eIF5A and  0.49  ±0.04 in the 
presence  of  Hyp-eIF5A) (Fig.  26C).  Likewise, the dHyp form  of  wild-type eIF5A 
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strongly stimulated  M-P-P-P-K  peptide synthesis (Ymax =  0.61 ±0.17). In contrast, 
whereas the Hyp forms  of eIF5A-H52A (Ymax =  0.46 ±0.02) and eIF5A-S74F (Ymax = 
>0.50) strongly stimulated  M-P-P-P-K synthesis, the dHyp forms  of these mutant 
proteins were partialy (dHyp-eIF5A-H52A, Ymax = 0.22 ±0.02) or substantialy (dHyp-
eIF5A-S74F, Ymax = not determined) impaired for stimulating M-P-P-P-K synthesis (Fig. 
26C). 
Because the eIF5A proteins purified from yeast sometimes contained mixtures of 
diferentialy  modified forms (±Hyp,  dHyp,  phosphorylation), I chose to repeat the 
analysis  using  preparations  of  unmodified, dHyp or Hyp forms  of eIF5A.  Recombinant 
eIF5A  was  purified from E. coli harboring a  plasmid that expresses the  wild-type  or 
mutant eIF5A alone (pC4181)  or co-expresses DYS1 (pC4182)  or  both DYS1 and LIA1 
(pC4183) (Fig.  26D).  ESI  QTOF  MS analyses confirmed the  presence  of  unmodified, 
deoxyhypusine- or  hypusine-containing forms  of eIF5A (Fig.  26E).  Unlike the  MS 
analyses for the eIF5A proteins purified from yeast (Fig. 25A-B & D), peaks representing 
unmodified eIF5A were present in E. coli co-expressing eIF5A and DHS. This presence 
of unmodified eIF5A in cels co-expressing eIF5A and DHS is consistent with previous 
reports  on eIF5A and  DHS co-expressed in  bacteria (Park et al.,  2011) and  with the 
reversibility  of the  DHS reaction in vitro (Park et al.,  2003). Despite the inability to 
obtain homogenous preparations of deoxyhypusine forms of eIF5A produced in E. coli, 
the unmodified and hypusine derivatives were obtained in good yield and devoid of the 
other forms  of eIF5A.  Similar to the eIF5A  proteins  purified from  yeast,  hypusine and 
deoxyhypusine forms  of eIF5A stimulated  M-P-P-P-K  peptide synthesis to similar 
extents (Ymax = 0.49 ±0.06 and Ymax = 0.50 ±0.10, respectively) (Fig. 26F). Hyp-eIF5A- 
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Figure 26. Stimulation  of  polyproline synthesis  by eIF5A  both in vivo and in vitro 
requires the hydroxyl group on hypusine. 
(A,B) Dual luciferase reporter constructs containing  10 repeats  of the AlaGCU  or 
ProCCA codon were introduced into isogenic LIA1+ (J1005)  or lia1Δ (J1119) yeast 
strains expressing the indicated form of eIF5A. Yeast were grown to OD600 = 1.0 at 30°C, 
and Renila and firefly luciferase activities were quantitated. Results were quantitated and 
normalized to the no insert control as described in Fig. 6. Eror bars were calculated as 
propagated standard deviations for three independent transformants. 
(C,F)  Electrophoretic  TLC analyses  of  peptide  products from elongation assays 
programmed to synthesize M-P-P-P-K. The identities of spots coresponding to M-P, M-
P-P, M-P-P-P, M-P-P-P-K and free methionine are indicated. The fraction of M-P-P-P-K 
synthesis in elongation assays lacking or containing wild-type or mutant eIF5A purified 
from  yeast (C)  or E. coli (F)  was  quantitated,  ploted, and fit to a single exponential 
equation.  Whether  prepared from  yeast  or E. coli,  100  nM  wild-type eIF5A,  100  nM 
eIF5A-H52A or 1 µM eIF5A-S74F was used in the peptide synthesis assays. 
(D)  Schematic  of  plasmids  pC4181,  pC4182 and  pC4183,  derived from  pST39 (Tan, 
2001), for co-expression of eIF5A, DYS1 and LIA1 in E. coli. Mutations in eIF5A were 
introduced by site-directed mutagenesis. 
(E) ESI QTOF MS analysis of recombinant N-terminal His6-tagged eIF5A, eIF5A-H52A, 
and eIF5A-S74F produced in E. coli (botom panels) or produced in cels co-expressing 
DYS1 (middle  panels)  or  DYS1 and  LIA1 (top  panels).  Peaks coresponding to Hyp, 
dHyp, and  unmodified (unmod.) forms  of eIF5A are  marked  by arows; and  peaks 
representing acetylated forms of eIF5A are marked with an asterisk (*). 
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H52A and  Hyp-eIF5A-S74F stimulated  M-P-P-P-K synthesis (Ymax =  0.45 ±0.05 and 
Ymax = >0.50, respectively),  while  unmodified eIF5A, eIF5A-H52A and eIF5A-S74F 
were  defective in stimulating  polyproline  peptide synthesis. Intriguingly,  dHyp-eIF5A-
H52A and  dHyp-eIF5A-S74F  were impaired in  M-P-P-P-K  peptide synthesis.  This 
inability  of the  deoxyhypusine forms  of eIF5A-H52A and eIF5A-S74F to robustly 
stimulate M-P-P-P-K synthesis is consistent with the in vivo reporter analyses (Fig. 26A) 
and indicate that the hydroxyl group on hypusine plays a crucial role for the function of 
eIF5A-H52A and eIF5A-S74F in polyproline synthesis. 
5.8 Conclusion 
The function  of the  hypusine  modification  on eIF5A, including its  hydroxyl  group, is 
poorly  understood.  While the LIA1 gene encoding  DOHH is  non-essential in  yeast, I 
isolated a distinct class of eIF5A mutants that require ful hypusine maturation for yeast 
cel  growth.  Al  of the  mutations lie  on the surface  of the  N-terminal  domain  of eIF5A 
with the eIF5A-H52A mutation located on the hypusine loop adjacent to the site of the 
modification and the S74F, N79I and C23Y,V60D mutations positioned on the “body” of 
eIF5A. In  polysome analyses, the eIF5A-H52A and eIF5A-S74F  mutants exhibited 
defects in translation, and further biochemical analyses of the mutants revealed that the 
hydroxyl  group  on  hypusine  promoted eIF5A function in  polyproline synthesis.  Thus, 
based on the proposed binding of eIF5A near the PTC of the ribosome, we propose that 
the hydroxyl group is an essential component of the hypusine modification and serves to 
position  hypusine such that it can enhance the synthesis  of  poor substrates like 
polyproline. 
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Based  on its ability to stimulate  Met-Pmn synthesis, eIF5A  was long thought to  be an 
initiation factor that  promoted formation  of the first  peptide  bond (Benne and  Hershey, 
1978; Glick and Ganoza, 1975; Kemper et al., 1976; Schreier et al., 1977). Later, it was 
shown, using elegant polysome profile analyses and in vitro translation experiments, that 
eIF5A  promotes translation elongation (Gregio et al.,  2009; Saini et al.,  2009).  As 
detailed in this dissertation, our work on eIF5A, concurent with studies on bacterial EF-
P, have provided new insights into the function of the two factors, and solidified a role 
for these factors in translation elongation and, in  particular, in the  production  of 
polyproline-containing  proteins. These data also  demonstrate a requirement for the 
conserved  hydroxyl  group  on  hypusine for eIF5A function in  protein synthesis. In this 
Discussion  Chapter, I  wil review the  newfound translation functions and recent 
developments of eIF5A/EF-P and their hypusine/β-lysyl-lysine modifications and discuss 
the broader implications of our work within the field. 
 
6.1 eIF5A and EF-P promote production of polyproline proteins 
At the time that I joined the  Dever lab in early 2011,  we  hypothesized that eIF5A 
functions to promote peptide bond synthesis of particular amino acids. Based on previous 
reports (Glick et al., 1979; Glick and Ganoza, 1975), we originaly proposed that eIF5A 
functioned in a similar manner to bacterial EF-P. We initialy focused our atention on the 
possible dependency for eIF5A in polyglycine and/or polyalanine synthesis using in vivo 
dual luciferase assays.  We chose to initialy test  polyglycine and  polyalanine  because, 
according to  Glick and coleagues, EF-P stimulatory activity  was  most  pronounced for 
dipeptide synthesis between fMet-tRNA and the A-site substrates C-A-Gly, C-A-Ala and 
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puromycin (Glick et al.,  1979).  However, I did  not  observe any significant  dependency 
for eIF5A in polyalanine or polyglycine synthesis in the reporter assays (Fig. 6B). (Note 
that the in vitro assays employed by Glick et al. were limited to the C-A acceptor ends of 
the aminoacyl-tRNA). With the work conducted by Ude and coleagues (Ude et al., 2013) 
and Doerfel and co-workers (Doerfel et al., 2013), who showed that EF-P enhanced the 
synthesis  of  proteins containing runs  of consecutive  proline codons, I used the  dual 
luciferase assay system to reveal the eIF5A requirement for polyproline peptide synthesis. 
Here, I describe the experiments conducted on EF-P and polyproline synthesis that set the 
stage for our work with eIF5A. 
Coming from a genetics perspective, Ude et al. found that production of CadC, a 
transcriptional regulator of the cadBA operon in E. coli, was impaired in cels lacking EF-
P  or its β-lysyl-lysine  modifying enzymes  YjeA/PoxA  or  YjeK (Ude et al.,  2013).  The 
sensitivity  of cadC mRNA translation to  defects in  EF-P function  was  mapped to a 
cluster  of  proline codons  within the cadC open reading frame.  Mutating these  proline 
codons substantialy restored cadC expression in cels lacking  EF-P.  Moreover, 
expression  of reporter constructs containing three  or  more consecutive  proline codons 
was diminished in cels lacking EF-P, and this efect was specific for proline as runs of 
five consecutive codons for each of the other 19 amino acids did not confer sensitivity to 
loss  of  EF-P function.  Coming from a  molecular  perspective and  based in  part  on 
previous findings that Gly and Pro are poor substrates for peptide bond formation (Pavlov 
et al.,  2009; Tanner et al.,  2009),  Doerfel and co-workers  used in vitro translation 
elongation assays to examine EF-P stimulation of peptide bond formation (Doerfel et al., 
2013).  Whereas  EF-P  did  not stimulate  M-P-F synthesis,  M-P-G and  M-P-P synthesis 
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was simulated  8- and  16-fold, respectively,  by addition  of  EF-P.  Synthesis  of  peptides 
containing longer stretches of proline residues showed practicaly an absolute dependence 
on EF-P. This requirement for EF-P was also observed when translating derivatives of the 
PrmC  protein  with the sequence  P-P-P  or  P-P-G inserted after the  19th codon  or  when 
translating native E. coli proteins containing polyproline sequences. Consistent with these 
studies,  polyproline sequences  were found to cause ribosomal staling in  bacteria in a 
manner that could be aleviated by addition of EF-P in vitro (Woolstenhulme et al., 2013). 
Taken together, this  work established a role for  EF-P in the specialized translation  of 
polyproline sequences, and demonstrated that EF-P function is not limited to first peptide 
bond synthesis. 
 Recently, three studies have further examined the sequence motifs that impose a 
requirement for  EF-P.  Two studies employed stable isotope labeling  by amino acids in 
cel culture (SILAC) to diferentialy label proteins expressed in bacteria that express or 
lack  EF-P (Hersch et al.,  2013; Peil et al.,  2013), and  Peil et al. also examined cels 
lacking the  modifying enzymes  yjeK,  yjeA  or  yfcM (Peil et al.,  2013).  Bioinformatic 
analysis  of the  data revealed  down-regulation  of  proteins containing  polyproline 
sequences especialy the  motifs  P-P-P and  P-P-G.  Systematic analyses  of reporter 
expression containing  various  X-P-P  or  P-P-Y  motifs revealed strong  EF-P  dependence 
when X was Pro, Asp or Ala and Y was Pro, Gly, Trp, Asp, or Asn (Peil et al., 2013). 
Interestingly, Hersch et al. reported that loss of EF-P impaired expression of several non-
proline containing  motifs  when inserted at the fourth codon  position  of a  GFP reporter 
(Hersch et al., 2013). However, when Peil et al. inserted these motifs into a lacZ reporter 
they did not observe EF-P dependence either in vivo or in vitro (Peil et al., 2013). Thus, it 
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remains to  be  determined  whether  EF-P contributes to the translation  of  non-proline 
containing motifs.  
A third report  utilized  genome-wide ribosome  profiling to examine  EF-
P−dependent ribosomal pausing on P-P-X motifs (Elgamal et al., 2014). X, in this case, 
represents any of the 20 amino acids. Though a surprisingly low number of P-P-X motifs 
(2.8% of al P-P-X motifs in the E. coli proteome) exhibited significant ribosome pausing 
(45-fold increase in ribosomal pausing at P-P-X motifs in cels lacking EF-P), Elgamal et 
al. found that  pausing  was largely  dependent  on sequences as far as three codons 
upstream of the second proline of the P-P-X motif (Elgamal et al., 2014). This suggests 
that interactions  of the  nascent chain  with constituents in the ribosome exit tunnel can 
influence the strength  of the ribosomal pause in the absence  of  EF-P.  Curiously,  no 
reliable corelation was observed when the ribosomal occupancies from cels lacking EF-
P were compared with representative total protein levels from previous proteomic SILAC 
data (Peil et al.,  2013).  Thus, it remains to  be seen if  other factors compensate for 
ribosomal pausing on P-P-X motifs or if the paused proteins are subject to quality control. 
Coincidentaly, this also raises the question of whether pausing of ribosomes translating 
polyproline sequences in the absence of EF-P (or eIF5A) targets the mRNAs to mRNA 
surveilance  mechanisms.  Finaly,  while these recent studies indicated that  polyproline 
sequences confer the  greatest  dependency  on  EF-P, the chemical  nature  of the  other 
amino acids that when juxtaposed with diproline impose EF-P dependency may provide 
new mechanistic insights into the interplay between the ribosome exit channel, the A-site 
substrate and the PTC of the ribosome. 
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 Consistent  with the reports  on  EF-P,  we reported that eIF5A likewise plays a 
critical role in the translation of polyproline motifs (Gutierez et al., 2013). A set of dual 
luciferase reporter constructs in  which the two luciferase  ORFs  were separated  by ten 
consecutive codons for each  of the twenty amino acids  were introduced into  wild-type 
and eIF5A mutant strains of yeast. Interestingly, expression from the reporter containing 
the run of proline codons was specificaly impaired in the eIF5A mutant (Fig. 6). This 3-
5–fold impact  of the eIF5A  mutation  on  polyproline reporter expression  was  observed 
when the polyproline insert was reduced from 10 to 8 or 6 codons, and was stil apparent, 
albeit with weaker impact, when only 3 or 4 proline codons were inserted in the reporter 
(Fig.  10).  Similar to this in vivo requirement for eIF5A stimulation  of  polyproline 
synthesis, polyproline peptide synthesis in a reconstituted yeast in vitro translation system 
was also dependent on eIF5A (Fig. 12). Addition of eIF5A modestly (<2-fold) stimulated 
M-P-K  or  M-F-F tripeptide synthesis, suggesting a  basic enhancement  of  peptidyl 
transferase activity that is  not specific for  proline. In contrast, synthesis  of a  peptide 
containing two consecutive  Pro residues  was stimulated  ~4-fold  by addition  of eIF5A, 
and the in vitro synthesis of a peptide containing three consecutive Pro residues showed 
absolute dependence on eIF5A. These data also suggest that the amino acid proline rather 
than the tRNA impose a requirement for eIF5A (Fig.  9C).  Future in vitro studies  using 
misacylated tRNAPro or an  Pro  mis-acylated  on a  non-cognate tRNA  may  define the 
precise tRNA and/or amino acid requirements for eIF5A in polyproline synthesis. 
 Further analyses  of ribosomes translating  polyproline sequences  have  provided 
insight into the requirement for EF-P or eIF5A. In the in vitro bacterial system, ribosomes 
translating the sequence P-P-G in the absence of EF-P staled with diproline bound to the 
	  
	   126 
P-site tRNA and  Gly-tRNA in the  A site (Doerfel et al.,  2013).  Likewise, toe-printing 
studies  of  bacterial ribosomes staled in vivo or in vitro on  polyproline sequences 
indicated that  proline is  bound to the  P-site tRNA and  Pro-tRNA is in the  A site 
(Woolstenhulme et al., 2013). Interestingly, Woolstenhulme et al. also found that both the 
length and amino acid sequence preceding the polyproline stretch afects the eficiency of 
staling, consistent with the notion mentioned above, that the conformation of the peptide 
in the active site and exit tunnel  of the ribosome can impose a requirement for  EF-P 
(Elgamal et al.,  2014). In experiments  performed in colaboration  with  Chris 
Woolstenhulme and  Alen  Buskirk, toe-printing studies  of eukaryotic ribosomes 
translating polyproline sequences in the absence of eIF5A likewise revealed staling with 
the second Pro codon in the P site (diproline bound to the P-site tRNA) and a Pro codon 
in the  A site (Gutierez et al.,  2013). Thus EF-P and eIF5A appear to rescue similarly 
staled complexes, suggesting that  both  proteins are required to  promote synthesis  of 
proline-proline peptide bonds needed to convert di-proline to tri-proline and higher-order 
polyproline sequences. 
 While no structures of eIF5A bound to the ribosome are available, the results of 
directed hydroxyl radical probing experiments indicate that eIF5A binds to a comparable 
site  on the eukaryotic ribosome as  EF-P  binds to the  bacterial ribosome.  Hydroxyl 
radicals generated by iron linked to the hypusine loop of eIF5A resulted in cleavages to 
the acceptor stem  of the  P-site tRNA and to rRNA at the top  of the  E and  P sites 
including the PTC of the ribosome (Gutierez et al., 2013). In addition, hydroxyl radicals 
generated by iron tethered to the “body” of eIF5A yielded cleavages on the side of the P-
site tRNA that faces the  E site.  Consistent  with the smaler size  of eIF5A compared to 
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EF-P, and the lack of domain II in eIF5A, there was no evidence that eIF5A contacts the 
smal ribosomal subunit.  Thus,  when  bound to the ribosome, eIF5A is  predicted to lie 
adjacent to the  P-site tRNA in a position that  partialy  overlaps the  E site  with the  N-
terminal domain of eIF5A lying close to the acceptor stem of the P-site tRNA. Due to its 
close  proximity to the acceptor stem  of the  P-site tRNA, the  hypusine  modification is 
predicted to extend near the PTC of the ribosome.  
Examination of the yeast proteome revealed that 549 out of 5886 proteins contain 
at least  one triproline  motif.  The  number  of  hits increases to  749 if  P-P-G  motifs are 
included as wel, and the number of hits increases to nearly 2000 if al poor P-P-X motifs, 
as defined for EF-P by Peil et al. (Peil et al., 2013), are included in the search. In humans, 
proline accounts for ~6% of the total encoded residues (Morgan and Rubenstein, 2013). 
Among ~18,000 human proteins, there are roughly 10,000 motifs consisting of 3 or more 
consecutive  proline residues (Morgan and  Rubenstein,  2013). In the analysis  of  protein 
expression in yeast, we reported that levels of the polyproline-containing proteins Ldb17 
(Fig. 11A), Eap1, and Vrp1 were reduced in eIF5A mutant strains (Gutierez et al., 2013). 
Moreover, the expression  of  Ldb17  was restored  when the  polyproline sequence in this 
protein  was  mutated to  polyalanine (Fig.  11B). In addition, the preliminary analysis  of 
ribosome  profiling  of the ts- eIF5A-S149P  mutant  has shown ribosome  pausing at 
polyproline sequences and a  dramatic loss  of ribosome  occupancy after the  polyproline 
segment in the TIM50 mRNA (Fig.  20).  At  present, it is stil  unclear  whether the 
polysome retention observed in polysome profile analyses upon inactivation of eIF5A in 
yeast (Fig. 8) reflects impaired translation elongation on the majority of celular mRNAs 
or is  due to impaired translation  of just the  mRNAs containing  polyproline  motifs. 
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Additional ribosome  profiling studies to  obtain  greater and  more in-depth coverage  of 
mRNAs combined  with  more specific  bioinformatics analyses  wil enable the 
identification  of the entire colection  of amino acid  motifs that require eIF5A for their 
translation.  However,  based  on ribosome  profiling  data from E. coli cels lacking  EF-P 
(Elgamal et al., 2014) and our ribosome profiling results, the most convincing amino acid 
sequence  motifs that strongly require eIF5A are those containing  polyproline.  The 
prevalence of polyproline motifs in yeast (95 out of 5886 proteins with motifs containing 
4 or more consecutive prolines) is consistent with eIF5A being essential in yeast; whereas, 
the efp gene can  be  deleted in E. coli in  which  only  9  out  of  ~4000  proteins contain 
motifs  of four  or  more  proline residues (Doerfel et al.,  2013). Interestingly,  while 
polyproline sequences are found in a variety of proteins in yeast, it is notable that several 
proteins involved in the actin cytoskeleton contain  polyproline  motifs.  Of  particular 
interest, the  protein  BNI1,  which functions in  polarized cel  growth, contains a 
polyproline sequence. Production of BNI1 is impaired in an eIF5A mutant strain (Li et al., 
2014) and, interestingly, overexpression of  BNI1 partialy suppresses the slow-growth 
phenotype of an eIF5A mutant yeast strain (Zaneli and Valentini, 2005). Based on this 
finding it seems reasonable to propose that the impacts of eIF5A mutants on the yeast cel 
cycle, cytoskeleton, and  PKC  pathways (Chaterjee et al.,  2006; Frigieri et al.,  2008; 
Galvao et al.,  2013; Valentini et al.,  2002), as  wel as the association  of eIF5A  with 
oncogenesis and,  paradoxicaly, tumor suppression in  mammals (Scuoppo et al.,  2012; 
Silvera et al.,  2010; Zender et al.,  2008),  may reflect impaired expression  of specific 
proteins containing polyproline sequences.  
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6.2 The requirement of the hypusine/β-lysyl-lysine modification for eIF5A/EF-P 
function in protein synthesis 
In addition to amino acid sequence and structural similarities, both eIF5A and EF-P are 
post-translationaly modified. As described earlier, the ε-amino group of a conserved Lys 
residue in eIF5A from some archaea and al eukaryotes is modified by DHS and DOHH 
to generate hypusine. Similarly, the E. coli gene products YjeA, YjeK and YfcM atach a 
β-lysine residue to the ε-amino  group  of a specific  Lys residue in  EF-P from some 
bacteria and then hydroxylate the side chain of the original Lys residue (Navare et al., 
2010; Peil et al., 2012; Roy et al., 2011; Yanagisawa et al., 2010). Interestingly, the Lys 
residue that is the site of the modification (Lys34 in E.coli EF-P) is substituted by Arg in 
some bacteria (e.g. T. thermophilus), and it is not known whether this Arg residue is post-
translationaly modified. Both the hypusine modification of eIF5A and the β-lysyl-lysine 
modification  of  EF-P are required for these factors to stimulate  polyproline synthesis 
(Doerfel et al., 2013; Ude et al., 2013) (Fig. 12D). Similar to E. coli strains lacking EF-P, 
loss  of β-lysinylation in E. coli impairs translation  of the  polyproline  motif in cadC; 
likewise, loss of β-lysinylation in Salmonela enterica alters the expression of a variety of 
celular proteins, impairs virulence in mice, and alters resistance to antibiotics (Navare et 
al.,  2010),  presumably  due to impaired translation  of  polyproline sequences.  Moreover, 
mouse models have shown that homozygous knockouts of eIF5A, DHS, or DOHH result 
in embryonic lethality supporting a critical function  of eIF5A and the  hypusine 
modification in mammalian development (Nishimura et al., 2012; Sievert et al., 2014). 
Recent studies  have further iluminated the  biosynthesis  of the β-lysyl-lysine 
modification  on  EF-P.  The initial studies  on the  EF-P  modification did  not  determine 
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whether YjeK acted before or after YjeA/PoxA added an extra molecule of lysine to the 
Lys34 side chain in E. coli EF-P.  However, further  biochemical analysis  of the β-
lysinylation reaction revealed that β-lysine  was a  much-prefered substrate for 
YjeA/PoxA than  was α-lysine (Km decreased  40-fold and  kcat increased  2-fold  with β-
lysine) (Roy et al., 2011). Thus, the EF-P modification pathway is predicted to proceed 
first  with conversion  of α-lysine to β-lysine  by  YjeK and then  with addition  of the β-
lysine to  EF-P  by  YjeA/PoxA to form β-lysyl-lysine (Fig.  27).  Analysis of  Met-Pmn 
synthesis in vitro using recombinant forms  of  unmodified and α- versus β-lysinylated 
EF-P  demonstrated the critical importance  of the β-lysyl-lysine  modification for  EF-P 
function (Bulwinkle et al., 2013; Park et al., 2012). 
Whereas β-lysinylation is  predicted to increase the  mass  of  EF-P  by  128  Da, 
analysis of native EF-P indicated that the modification increased EF-P mass by 144 Da 
(Aoki et al.,  2008; Peil et al.,  2012).  This  discrepancy  was resolved  when  Peil et al. 
demonstrated that  YfcM (EpmC)  hydroxylates the  original lysine side chain  of the 
modified residue in  EF-P (Peil et al.,  2012).  Moreover,  MS analysis  of  purified E. coli 
EF-P established that β-lysine is atached to the ε-amino  group  of  Lys34 (Peil et al., 
2012). Thus, similar to the conversion of deoxyhypusine to hypusine by DOHH, YfcM 
adds a hydroxyl group (+16 Da) to complete the post-translational biosynthesis of the β-
lysyl-lysine  modification  on  EF-P (Fig.  27).  However, in contrast to eIF5A,  where the 
hydroxyl  group is added to the spermidine-derived  portion  of the  modification, the 
hydroxylation of EF-P is directed to the γ or δ carbons of the Lys34 sidechain (and not to 
the added β-lysine) (Peil et al., 2012). Interestingly, similar to the minimal efect of LIA1 
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deletion in  yeast, loss  of yfcM in E. coli did  not afect  bacterial  growth  or antibiotic 
sensitivity (Bulwinkle et al., 2013). 
 
Figure 27. Post-translational modification pathway for EF-P. 
In  bacteria, β-lysinylation  of  EF-P  occurs in three steps catalyzed  by  YjeK (EpmB), 
YjeA/PoxA (EpmA) and  YfcM (EpmC).  First,  YjeK, a lysine aminomutase, converts 
lysine to β-lysine.  Next,  YjeA/PoxA catalyzes the addition  of β-lysine  onto a specific 
lysine residue in  EF-P (Lys34  of E. coli EF-P). In a final step,  YfcM  hydroxylates the 
lysine residue. 
 
Yeast lacking LIA1 grow slightly slower than  wild-type strains. In addition, 
recent studies  have linked loss  of LIA1 to a  defect in synthesis  of the  polyproline-
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containing BNI1 protein, resulting in an impaired ability of yeast to shmoo and mate (Li 
et al., 2014). In contrast to loss of LIA1 in yeast, loss of DOHH is recessively lethal in C. 
elegans (Sievert et al., 2014; Sugimoto, 2004), Drosophila (Patel et al., 2009), and mouse 
(Sievert et al., 2014). Thus, the hydroxyl group may be more critical for eIF5A function 
in  higher eukaryotes and  multi-celular  organisms. In my studies  of the  hypusine 
modification  on eIF5A, I focused  on the role  of the  hydroxyl  group  on  hypusine and 
identified a colection of eIF5A mutants that require hydroxylation of deoxyhypusine for 
yeast cel growth (Fig. 21). The LIA1-dependent mutations in HYP2 were localized to the 
N-terminal  domain  of the eIF5A  protein (Fig.  22).  Folowing  discovery  of these LIA1-
dependent eIF5A mutants, we investigated whether the synthetic growth defects in these 
mutants could be explained by negative impacts on eIF5A protein levels, the stability of 
the  hypusine  modification,  or eIF5A function.  Western analyses revealed that the 
mutations did not diminish protein levels (Fig. 24), and MS analyses demonstrated that 
the mutations did not result in the accumulation of unmodified forms of eIF5A (Fig. 25). 
This later result is inconsistent  with cel-free experiments that suggested that the 
hydroxylation  of  deoxyhypusine to  hypusine  blocks the reversible back reaction  of 
deoxyhypusine to  unmodified eIF5A (Park et al.,  2003).  Also at  odds  with this result, 
recent evidence from  Sievert et al.  have shown that  mouse  3T3 cels lacking  DOHH 
accumulate  unmodified eIF5A (Sievert et al.,  2014). It is  unclear  whether  diferences 
between  yeast and  mammalian  DHS  underlie the  diferential requirement for the 
hydroxyl  group to  prevent the  back reaction  of  deoxyhypusine to  unmodified eIF5A. 
Preventing the  back reaction and the accumulation  of  unmodified eIF5A  by 
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hydroxylating  deoxyhypusine to  make  hypusine  may  be  necessary to ensure adequate 
pools of Hyp-eIF5A for early mammalian development. 
These data  demonstrate that the  hydroxyl  group  on  hypusine  has a  primary 
function in  protein synthesis and in translation  of  polyproline  motifs. Although loss  of 
LIA1 results in a minor slow-growth and shmooing defect in yeast (Li et al., 2014), our 
studies suggest that lia1Δ is hypomorphic and displays exacerbated growth defects when 
combined with an eIF5A mutant. My data, using in vivo reporter and in vitro translation 
assays, revealed that the dHyp forms  of eIF5A-H52A and eIF5A-S74F are  defective in 
stimulating polyproline synthesis (Fig. 26). Thus, the synthetic growth defects associated 
with these eIF5A mutants in the lia1Δ background can be atributed to an impairment of 
the eIF5A mutants in the translation of polyproline sequences. As shown above, the MS 
analysis  of eIF5A-H52A  purified from  yeast confirmed the  presence  of  Hyp-eIF5A-
H52A and dHyp-eIF5A-H52A in LIA1+ strains. This is consistent with previous reports 
that coresponding  mutations in the  hypusine loop  of  human eIF5A impair  DOHH 
recognition (Cano et al.,  2008; Kang et al.,  2007).  Notably, in addition to the apparent 
elongation defect (Fig. 23B) and reduced stimulation of polyproline synthesis by dHyp-
eIF5A-H52A (Fig. 26C&F), eIF5A-H52A is impaired in hypusine formation. Curiously, 
whereas  50-100  nM eIF5A  was suficient to stimulate  M-P-P-P-K synthesis in the in 
vitro assays,  1  µM eIF5A-S74F  was added to the same assays in  order to  observe 
moderate M-P-P-P-K synthesis. In addition to the hypusine hydroxyl group requirement 
for M-P-P-P-K peptide synthesis, the eIF5A-S74F mutant may be impaired in productive 
binding to the ribosome reflected by the 10-fold higher k1/2 value for eIF5A-S74F versus 
wild-type eIF5A in my assays (data not shown). While additional structural and binding 
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experiments  with  80S initiation complexes  may  be  necessary to  gain insights into the 
dynamics  of eIF5A-H52A and eIF5A-S74F  binding to the ribosome and to  define the 
critical interactions  of eIF5A residues  with the  80S ribosome and  P-site tRNA,  we 
propose that the  primary function  of the  hydroxyl  group is to  position the  hypusine 
residue in the PTC to promote peptide bond formation for poor substrates like proline.  
 
6.3 eIF5A is the keymaster that presents hypusine to the ribosome active site 
Previous studies revealed that peptidyl-prolyl-tRNA in the ribosomal P site reacts poorly 
with puromycin (Muto and Ito, 2008) and that proline is an ineficient A-site substrate for 
peptide  bond formation (Pavlov et al.,  2009). These data, as  wel as the recent studies 
with  EF-P (Doerfel et al.,  2013; Ude et al.,  2013; Woolstenhulme et al.,  2013), 
demonstrated that combining peptidyl-diprolyl-tRNA in the P site with a poor substrate 
like  prolyl-tRNA in the  A site  dramaticaly impairs  protein synthesis and establishes a 
dependency for eIF5A/EF-P and their hypusine/β-lysyl-lysine modifications (Fig. 28). At 
present, it is  not clear  why  polyproline is such a  poor substrate for  protein synthesis; 
however, it  may reflect the imino acid  nature  of  proline, the geometrical  or steric 
constraints of a cyclic side chain, or the unique ability of proline to readily sample both 
cis and trans conformations of peptide bonds (Ramachandran and Mitra, 1976). Perhaps 
insertion of the extended hypusine (or β-lysyl-lysine) side chain into the PTC stabilizes 
the proper conformation of the PTC or restricts the conformation of proline in the P site 
enabling a favorable  geometry for  peptide  bond formation  with the  A-site amino acid. 
While the  data reported in this thesis and the recent studies  on  EF-P establish that 
translation of homopolyproline motifs requires eIF5A/EFP, additional studies, including 
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more extensive ribosome profiling of wild-type and eIF5A mutant strains, wil be needed 
to  define the spectrum  of amino acids and  motifs that rely  on eIF5A  or its  hypusine 
modification for their eficient translation. In addition, structural (X-ray crystalography 
and cryo-electron  microscopy (EM) and  biochemical (single-molecule fluorescence 
resonance energy transfer (FRET) studies  wil  provide  greater insights into the 
mechanism by which eIF5A and its hypusine modification interact with the ribosome or 
diprolyl-tRNA in the ribosomal P site to promote peptide bond formation. 
 
Figure 28. Model of eIF5A stimulating polyproline synthesis. 
Model of ribosome staled on polyproline sequence with di-proline atached to the P-site 
tRNA and  Pro-tRNAPro in the  A site (left). (Right)  Binding  of eIF5A  near the  E site 
places the hypusine side chain (Lys51, green) adjacent to the peptidyl-tRNA in the PTC 
of the ribosome  where it helps promote  peptide  bond formation  with the amino acid 
atached to the A-site tRNA. Figure taken from Gutierez et al. (Gutierez et al., 2013). 
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 After formation  of  Pro-Pro  peptide  bonds,  we  presume that tRNAs move into 
hybrid P/E and A/P states and that eEF2 promotes translocation of the tRNAs and mRNA 
on the ribosome. This results in the deacylated tRNA and the peptidyl-tRNA in the E and 
P sites, respectively.  Before the start  of the  next elongation cycle or entry into the 
translation termination phase, I propose that eIF5A vacates the ribosomal P/E site, thus 
freeing the E site for the next round of translocation. Future structural and biochemical 
studies wil iluminate the dynamics of eIF5A on the ribosome with poor substrates like 
diprolyl-tRNA in the  P site. It  wil also  be interesting to determine whether eIF5A 
contributes to elongation regardless  of the substrate (e.g.  prolyl-tRNA  or  phenylalynyl-
tRNA) in the P and A site. Notably, incorporation of phenylalanine into peptide bonds is 
stimulated by eIF5A in vitro (Fig. 12B). 
 
6.4 eIF5A/EF-P: the third universaly conserved elongation factor  
Whereas eIF5A  was thought to function as translation initiation factor based  on its 
activity in Met-Pmn assays, puromycin, an aminoacyl analog that reacts wel with most 
peptidyl-tRNA substrates, reacts  poorly  with fMet-tRNAfMet and  with  peptidyl-tRNA 
substrates  with a  C-terminal  proline (Wohlgemuth et al.,  2008). In contrast, these later 
substrates react  wel  with authentic aminoacyl-tRNAs (Wohlgemuth et al.,  2008).  The 
poor reactivity  with  puromycin  has  been atributed to  poor substrate  positioning in the 
active site of the ribosome (Wohlgemuth et al., 2008; Youngman et al., 2004). Thus, the 
Met-Pmn synthesis assay is likely not a god mimic of first peptide bond formation, and 
the eIF5A stimulation of Met-Pmn synthesis might reflect activities of the factor distinct 
from first  peptide  bond synthesis. Consistent  with this  notion, the  kobs (data  not shown) 
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and the  Ymax for  M-P  or  M-F synthesis  were  only  modestly afected by adding eIF5A 
(Fig.  12); and recent studies, likewise, showed that EF-P does  not stimulate  dipeptide 
formation (Bulwinkle et al., 2013; Doerfel et al., 2013). These results argue that eIF5A 
and EF-P do not have a specific function in first peptide bond synthesis. However, it is 
noteworthy that consistent  with a function in translation elongation, inactivation  of 
eIF5A/EF-P (Bulwinkle et al.,  2013; Saini et al.,  2009) (Fig.  8) mimics the efects  of 
elongation inhibitors and causes  polysome retention.  Taken together, the  puromycin, 
peptide synthesis and polysome analyses indicate that the primary function of eIF5A and 
EF-P is to  promote  peptide  bond formation, especialy for  poor substrates like 
polyproline. 
 In addition to the  universaly conserved translation factors, eEF1A/EF-Tu and 
eEF2/EF-G, three other factors have been implicated in translation elongation. However, 
these later factors are  not  universaly conserved.  The factor eEF3 is proposed to 
coordinate E-site tRNA release with eEF1A–aminoacyl-tRNA binding to the A site of the 
ribosome in some fungi including S. cerevisiae (Anand et al., 2006; Triana-Alonso et al., 
1995). Bacterial EF4 (LepA) is proposed to maintain rapid protein synthesis under stress 
conditions such as  high ionic strength and low temperature (Pech et al.,  2011), and 
SelB/eEFsec is an EF-Tu ortholog required for the delivery of selenocysteinyl-tRNA to 
the ribosome (Driscol and Copeland, 2003). Our results studying eIF5A concur with the 
findings on EF-P (Doerfel et al., 2013; Ude et al., 2013) and demonstrate that eIF5A/EF-
P is required for translation of polyproline sequences. This conservation of eIF5A/EF-P 
in al  bacteria, archaea, and eukaryotes that  have  been examined, combined  with the 
common function  of these factors, leads  us to conclude that eIF5A/EF-P is the third 
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universaly conserved translation elongation factor. Based on its clarified role in protein 
synthesis,  we  propose that eIF5A  be appropriately renamed as an elongation factor: 
eukaryotic elongation factor  5 (eEF5).  As  many advances  have  been achieved in the 
study  of eIF5A/EF-P  over the  past four  years, it  wil  be interesting to folow as  newer 
technologies  present  opportunities to  gain additional insights into the function and 
mechanism of this enigmatic translation factor. 
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7.1 Appendix: Glossary of Abbreviations 
5-FOA  5-fluoroorotic acid 
AEBSF  4-(2-aminoethyl) benzenesulfonyl fluoride hydrochloride 
ATP   adenosine-5’-triphosphate 
CHO   chinese hamster ovary 
CHX   cycloheximide 
CTP   cytidine-5’-triphosphate 
DHS   deoxyhypusine synthase 
dHyp   deoxyhypusinated 
DOHH  deoxyhypusine hydroxylase 
eEF   eukaryotic elongation factor 
EF   elongation factor 
eIF   eukaryotic initiation factor 
ESI QTOF MS ElectroSpray-Ionization Quadrupole-Time-of-Flight Mass 
Spectrometry 
fMet   formylmethionyl 
IF   initiation factor 
GC7   N1-guanyl-1,7-diaminoheptane 
GTP   guanosine-5’-triphosphate 
Hyp   hypusinated 
Met-Pmn  methionyl-puromycin 
Met-tRNAi
Met  initiator methionyl-tRNA 
MW   molecular weight 
ORF   open reading frame 
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PBS   phosphate-bufered saline 
Pi   inorganic phosphate 
P/M   polysome to monosome 
PTC   peptidyl transferase center 
SC   synthetic complete 
SILAC  stable isotope labeling by amino acids in cel culture 
TBS   tris-bufered saline 
TCA   trichloroacetic acid 
TLC   thin-layer chromatography 
ts-   temperature-sensitive 
UTR   untranslated region 
WCE   whole-cel extract 
YNB   yeast nitrogen base 
YPD   yeast peptone dextrose 
YPGAL  yeast peptone galactose 
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